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One of the main mechanisms contributing to neurodegenerative diseases (NDD) 
is oxidative stress, caused by the buildup of reactive oxygen species (ROS) in the 
brain. Chronic neuroinflammation is also involved with the pathology of NDD; 
when microglia are activated in response to the dysfunction and aggregation of 
alpha-synuclein and amyloid-beta, they release inflammatory mediators. NDD 
are linked to glutamate-mediated excitotoxicity as well, where cells are damaged 
by the excessive stimulation from glutamate via inadequate uptake by glial cells. 
Polyphenols, found in very high levels in blueberries, have antioxidant 
properties which may offer protection and intervention from neurological 
disorders by managing ROS and reducing the inflammatory response. 
Biochemical analysis was performed on extracts from frozen wild Newfoundland 
fruits and leaves, Vaccinium angustiform spp. Mouse-pup derived brain cultures, 
and pure cultures of rat neurons and microglia were exposed to 100μM 
glutamate, 100ng/ml alpha-synuclein or 7.5μM amyloid-beta for 24-hours, which 
decreased cell viability. Overall, there was an increase in the number of viable 
cells once blueberry extract was added, effectively reducing neuronal and 
microglial cell death, showing that compounds in berries are beneficial when cell 
death and damage is influenced by glutamate-mediated excitotoxicity or 
insoluble alpha-synuclein and amyloid-beta aggregates. The blueberry extracts 
have high antioxidant activity and therefore may be able to help combat 
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Chapter 1: Introduction 
1.1 General  
We are now in an era where the world’s population is living longer than 
ever, so age-related diseases such as Parkinson’s (PD), Alzheimer’s (AD), and 
Huntington’s disease (HD) are becoming more and more common (Figueira et al., 
2017; Cirmi et al., 2016). There is no cure for these neurodegenerative diseases 
(NDD), as the drugs and other therapies available only relieve the symptoms 
associated with the disease and have no effect on its pathology (Ataie et al., 2016; 
Strathearn et al., 2014). Only a small portion of NDD cases are caused by 
environmental or genetic factors, as the genetic basis of the majority of NDD is 
poorly understood. Most cases are sporadic or idiopathic and are very difficult to 
diagnose (Aarsland & Kurz, 2010; Ataie et al., 2016). Neurodegeneration is the 
progressive loss of neuronal structure and function and is common even when a 
NDD is not present. Over time, as we age the body loses its ability to maintain 
and produce new nervous tissue, which can lead to many cognitive and motor 
impairments.  
One of the main mechanisms contributing to NDD is oxidative stress, which 
is caused by the buildup of harmful reactive oxygen species (ROS) in the brain 
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(Ataie et al., 2016). Neuroinflammation, which is the inflammation of nervous 
tissue, is also associated with the development and pathology of many NDD. For 
example, when microglia, the immune cells in the CNS, become over-activated 
this promotes the release of excess pro-inflammatory mediators which can lead to 
chronic neuroinflammation resulting in tissue damage (Morales et al., 2014). NDD 
are linked to glutamate-mediated excitotoxicity as well, where cells are damaged 
by the excessive stimulation from glutamate, an excitatory neurotransmitter, via 
inadequate uptake by glial cells (Figueira et al., 2017).  
Identifying a potential drug or compound which is able to prevent further 
neuronal loss and/or reverse some of the damage is extremely difficult but very 
important as neurons are not as actively replaced by the body compared to other 
cell types, especially in an aging brain. Polyphenols are a natural antioxidant 
product associated with minimal risk in terms of toxicity and adverse side effects 
(D’Archivio et al., 2008). Natural polyphenols have been shown to be preferred 
by individuals compared to synthetic antioxidant products (Papas, 1999).  
1.2 Taxonomy  
The goal of this study is to examine the neuroprotective role of low-bush 
wild blueberries, Vaccinium angustifolium, which are native to Newfoundland and 
Labrador. Vaccinium species belong to the family Ericaceae and are most 
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commonly found in eastern and central North America (Kloet, 1983). They are a 
perennial shrub which grow to be about 6-inches to 2-feet tall (Kloet, 1983). The 
buds produce a small white bell-shaped flower which is then followed by a blue 
fleshy fruit. The branches are small and thin, with glossy foliage that is 
green/blue in the spring and summer, and turns green/red in the fall (see Figure 
1.1). V. angustifolium are very tolerant to a wide range of soils and climates (Kloet, 
1983). They can be found growing in acidic, moist or droughty soils, which are 
generally very challenging for other plant species. They typically grow on alpine 
or subalpine zones, cliffs, ledges, grasslands, and mountain summits (Morrison et 
al., 2000), where they are exposed to harsh winds and little shade. V. angustifolium 
are grown commercially in Canada, mainly in Nova Scotia and Quebec, as well 
as areas across the United States (Morrison et al., 2000).  
1.3 Blueberries as Nutraceuticals  
Nutraceuticals are commonly defined as any substance that is considered a 
food, a part of food, a vitamin, a mineral or an herb that provides health benefits, 
including disease prevention and/or treatment (Raskin et al., 2002; Vyas et al., 
2013). The use of botanical nutraceuticals for their antioxidant properties and 
overall health benefits have been investigated not only within the Vaccinium 
genus but also all across the plant kingdom (Vyas et al., 2013). For example, grape 
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seeds (Strathearn et al., 2014), walnuts (Orhan et al., 2011), plums (Strathearn et al., 
2014), and myrtle (Tumen et al., 2012) have been investigated as potential 
neuroprotective agents. Berries however, are the most researched plant species 
for phenolic studies and have been proven to contain very high levels of 
polyphenols compared to other plant species (Papandreou et al., 2012; Balk et al., 
2006). Blueberries, in particular, contain the highest amount of polyphenols, 
anthocyanins and antioxidant activity among other berries studied (Poiana et al. 
2010; Joseph et al., 1999; Vyas et al., 2013). Blueberries contain several different 
kinds of polyphenols that can work together and have a synergistic effect in the 
CNS (Tavares et al., 2013). This is important, particularly with regard to the 
localization of a particular antioxidant in the brain (Joseph et al., 1999), and for 
activating neuroprotective response pathways (Strathearn et al., 2014). Berries are 
very promising because they have more than one mechanism of action when it 
comes to neuroprotection. For example, the polyphenols found in blueberries 
have antioxidant properties that may offer protection and intervention from 
neurological disorders by managing ROS (Cirmi et al., 2016; Strathearn et al., 
2014; Gao et al., 2012), reducing the inflammatory response (Figueira et al., 2017; 
Morales et al., 2016), and providing protection in the brain from further 
degeneration (Fuentealba et al., 2011; Takahashi et al., 2015; Macedo et al., 2015). 
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Figure 1.1: Vaccinium angustifolium. Lowbush wild blueberry species native to 
Newfoundland and Labrador.   
1.4 Phenolics and Polyphenols 
Polyphenols found in several species of plants, particularly blueberries, are 
botanical nutraceuticals with antioxidant properties. Polyphenols are known to 
have other health benefits as well such as anti-inflammatory, anti-cancer, and 
anti-infective properties (Vyas et al., 2013; Virmani et al., 2013). Polyphenols may 
have indirect peripheral effects in the brain (Figueira et al., 2017) such as 
improving cardiovascular health resulting in increased blood flow to the brain 
(Slemmer & Weber, 2014). Some antioxidants are found in the body naturally 
while others need to be obtained in the diet (Vyas et al., 2013). 
There are more than 8,000 known phenolic structures (Dai & Mumper, 
2010), composed of one or more aromatic rings with several hydroxyl groups 
attached (see Figure 1.2). Different classes of polyphenols exist based on their 
number of phenol rings and what structural element is present for binding them 
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together (D’Archivio et al., 2007). It is important to determine the levels of 
polyphenols and the free radical scavenging ability of a particular sample to 
better understand the factors that influence phenolic content. Polyphenol content 
in a particular sample depends on several environmental factors such as soil 
composition, temperature, exposure to ultra-violet (UV) radiation, wind, rainfall 
and elevation (Chu et al., 2011; Manach et al., 2004). Ripeness also plays a role in 
the levels of phenolic compounds present in a berry sample (Manach et al., 2004). 
Generally, the concentration of most phenolic compounds tend to decrease 
during ripening, however the concentration of anthocyanins (see section 1.4.2) 
increase. After the collection of berries, the type of storage can affect the 
polyphenol concentration as well, as polyphenols are easily oxidized (D’Archivio 
et al., 2007). However, there is no significant difference between the antioxidant 
activity of extracts from fresh blueberries and berries that are frozen 
(Lohachoompol et al., 2004). Berries can maintain high phenolic levels when 
frozen for a long period of time (Lohachoompol et al., 2004), and therefore this 
type of storage can maintain the integrity of the compounds of interest.  A study 
out of Italy in 2013 examined the difference between the polyphenol content in 
wild versus cultivated blueberries (Braga et al., 2013). They determined that 
polyphenol levels were significantly greater in wild extracts, particularly 
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anthocyanin levels. They also determined through COMET assay, a technique 
used to detect deoxyribonucleic acid (DNA) damage in a cell, that there was 
strong DNA protection with wild blueberry samples compared to the cultivated 
samples. 
 
Figure 1.2: Basic phenolic structure. Polyphenols are composed of one or more 
aromatic rings with several hydroxyl groups attached. 
Polyphenols can be classified into five major groups: diferuloylmethanes, 
stilbenes, flavonoids, phenolic acids and tannins (Pandareesh et al., 2015). In a 
previous study in Dr. Weber’s lab (here and after referred to as “our lab”) (Vyas 
et al., 2013), it was determined that in addition to the fruits containing high levels 
of phenolic compounds in both blueberries and lingonberries, the leaves 
exhibited much higher levels and proved to be more neuroprotective in an in 
vitro model of glutamate-mediated excitotoxicity. Thus, studies should include 
other plant components instead of just the fruits.  
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Figure 1.3: Phenolic family classification. 
Adapted from “B Vitamins and Berries and Age-Related Neurodegenerative 
Disorders” by Balk et al. (2006) and “Dietary Polyphenols and Their Biological 
Significance” by Han et al., 2007.  
1.4.1 Tannin 
A tannin is an astringent, polyphenol that has a bitter taste (Han et al., 
2007). Tannins are water-souble and are particularly prominent in unripened or 
bitter fruits and vegetables (Han et al., 2007). Wines contain high levels of tannins 
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and are responsible for the “drying” feeling in the mouth when consumed. Wine 
can have strong or weak tannins depending on how long the juice sits with the 
grapes after they have been pressed; red is usually higher than white. Tannins 
also play a role in plant defense; because they are highly astringent and 
concentrated in unripened fruits this often results in a reduction in consumption 
by animals. This is beneficial for the plant because the fruits are not consumed 
until the seeds are mature and ready for dispersal, which is important for seed 
survival (Mehansho et al., 1987).   
1.4.2 Flavonoids 
Flavonoids are the largest naturally occurring group of polyphenols, and 
are the most abundant polyphenols in our diets (Han et al., 2007). They are 
composed of two aromatic rings which are bound together by three carbon atoms 
to form an oxygenated heterocycle (Manach et al., 2004). Flavonoids can be 
further divided into two groups: anthoxanthins, which are colourless and 
composed of four subgroups, and the anthocyanins, which are responsible for the 
colour seen in many fruits and vegetables (Han et al., 2007). The major flavonoids 
found in berries are anthocyanins and flavonols (Cho et al., 2004), which are also 
responsible for the blue and red colours present in most berries (Hossain et al., 
2016). Generally, the darker the berry the higher the antioxidant activity. Berries 
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store the majority of their anthocyanins in the skin, which help protect the fruit 
from harmful interactions with the sun and other environmental factors (Hossain 
et al., 2016). Blueberries contain at least five different anthocyanins, catechin 
being the most common. Catechin is often used as a standard (catechin 
equivalent) for quantifying levels of polyphenols in samples (D’Archivio et al., 
2007).  
Flavonoids are the main compounds responsible for the major antioxidant 
activity of berries (Balk et al., 2006; Pandareesh et al., 2015). This is consistent with 
results from Strathearn et al. (2014) where they determined that anthocyanins and 
pro-anthocyanins were better able to suppress the neurodegenerative effects of 
rotenone in a cell model of PD compared to other phenolic compounds found in 
their blueberry extract.  
1.5 Bioavailability  
The overall health benefits of consuming polyphenols are directly related to the 
bioavailability and the amount consumed (Manach et al., 2004). The absorption of 
polyphenols is highly dependent on the rate of metabolism and the microflora 
present within the body.  The body is highly complex and there are a several 
steps that affect bioavailability including initial ingestion, absorption, plasma 
transport, elimination, cellular uptake, and crossing the blood-brain-barrier (BBB) 
 11 
(Manach et al., 2004; Kelly et al., 2017). Polyphenols are not absorbed with equal 
efficacy; the bioavailability of polyphenols is largely concerned with the structure 
of active phenolic metabolites crossing the BBB, which depends on a number of 
factors such as size and lipophilicity (Weber et al., 2012; Tavares et al., 2013).  
Polyphenols are not taken up equally into all brain areas, for example, 
vitamin E uptake is lower in the striatum compared to other brain areas (Joseph 
et al., 1999). Papandreou et al. (2012) found that different phenolic compounds 
present in blueberries had differences in the underlying neuroprotective 
mechanisms based on the characteristics of a specific cell line. For example, some 
cell lines required a higher concentration of berry extract than others to elicit 
protection against hydrogen peroxide-mediated cell death. These differences 
could be the chemical structure of the phenolic compound, and how it interacts 
with different cell surface receptors, or the unique cellular membrane 
composition of a particular cell type (Papandreou et al., 2012). 
Previous studies have detected the presence of particular polyphenols in 
the CNS showing that they are able to cross the BBB (Kelly et al., 2017; Krikorian 
et al., 2010; Andres-Lacueva et al., 2005). Anthocyanins have been identified in 
several brain areas and have been associated with neuroregeneration and 
protection (Krikorian et al., 2010). Specifically, Talavera et al. (2005) showed that 
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anthocyanins were detected in the CNS after oral administration of a blackberry-
enriched diet to rats. Similarly, Andres-Lacueva et al. (2005) showed that after 
eight weeks of feeding with a 2% blueberry-enriched diet, anthocyanins from the 
blueberry extracts were found in the cerebellum, cortex, hippocampus and 
striatum in 19-month-old rats.  
1.6 In vitro and in vivo studies 
There are many advantages and disadvantages to studying the 
neuroprotective effects of polyphenols with both in vitro and in vivo experiments. 
The majority of experiments are conducted in vitro (Han et al., 2007; Fuentealba et 
al., 2011; Takahashi et al., 2015; Macedo et al., 2015), as they are more accessible, 
provide faster results, can use specific cell lines, and are generally less expensive 
than in vivo studies (Kelly et al., 2017; Slemmer & Weber, 2014). In vivo models, 
which use oral administration to administer polyphenol-enriched diets (Slemmer 
& Weber, 2014), are generally more expensive and time consuming but are very 
important because they imitate the bioavailability and concentration of active 
metabolites in particular brain areas (Kelly et al., 2017; Slemmer & Weber, 2014). 
With in vivo studies, different motor and cognitive tests can be performed to see if 
the addition of a particular compound can be beneficial. Motor and cognitive 
deficits accompany many NDD, such as PD and AD. In vitro studies, although 
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very important, only show the effects on a cellular level, i.e. the increase or 
decrease of cell death or levels of toxic protein. Therefore, being able to perform 
cognitive and motor tests in an in vivo model allows the researcher to observe 
significant behavioral changes over time. Previous in vivo studies (Atcha et al., 
2010; Grace et al., 2009; El-Mohsen et al., 2006), including those conducted in our 
lab, primarily use oral gavage as the main route of administration for 
polyphenol-enriched diets. This method is very invasive however, and has been 
shown to potentially cause extensive internal damage such as throat and oral 
damage, lung perforation and aspiration, and restraint-associated injuries 
(Vandenberg et al. 2014). Oral gavage can be very stressful for the animals, 
resulting in an increase in plasma levels of corticosterone, glucose, growth 
hormone, and prolactin (Balcombe et al. 2004). Other routes of administration 
such as voluntary consumption of these special diets has not yet been thoroughly 
investigated. Therefore, it would be beneficial to explore these other options 
which would reduce injury and mortality of the animals involved in the study, 
and reduce their overall stress levels so that results, particularly regarding 
behavioral tests, are not influenced. It would also be beneficial to look at the 
bioavailability of an alternate route of administration. When an animal is fed via 
oral gavage the compounds are deposited directly into the stomach. Therefore, 
 14 
the compounds are not chewed or swallowed resulting in a decrease in 
absorption and metabolite breakdown from the esophageal mucosa and epithelia 
(Vandenberg et al. 2014). A study conducted by Atcha et al. (2010) showed that 
those animals fed by oral gavage compared to those animals that freely 
consumed and swallowed the pharmaceutical donepezil had lower blood and 
brain concentrations of the drug. 
1.7 Antioxidants and Oxidative Stress 
One of the main mechanisms of neurodegeneration is from the increased 
and long-term effects of oxidative stress. All cells need to utilize O2 for cellular 
respiration, however it is important that oxygen is managed correctly and 
efficiently to prevent cell damage. Oxidative stress in the CNS is caused when 
ROS build up faster than the endogenous redox reactions can eliminate them 
(Ataie et al., 2016). Disruption of the sensitive regulation of ROS and balance of 
antioxidants can lead to cell death and damage (Cirmi et al., 2016). In addition, 
nitrosative stress, similar to oxidative stress, occurs when reactive nitrogen 
species (RNS) build up in the cell and additively contribute to the free radical 
load. Free radicals, ROS and RNS, are missing one or more electrons so they 
attack other molecules, such as cell structures, membranes, and DNA to replace 
their missing charge. This results in extensive cell damage and eventual cell 
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death. Healthy cells are capable of performing redox reactions to keep ROS and 
RNS in check, however cell damage and death occurs when these systems are 
overloaded (Cirmi et al., 2016).   
Redox reactions involve the transfer of electrons, and are very important in 
many biological processes such as cellular respiration and photosynthesis (Cirmi 
et al., 2016). Oxidation is a process that occurs in all aerobic organisms, which 
refers to the loss of electrons. Free radicals can be produced during redox 
reactions when an electron detaches from a molecule. If the electron does not 
reattach to the molecule or an antioxidant it can cause extensive damage in the 
cell and surrounding area (Ataie et al., 2016). NADH dehydrogenase is an 
enzyme in the mitochondria responsible for the transfer of electrons. Many NDD 
affect this site in the mitochondrial electron transport chain which allows 
electrons to escape, leading to an increase in ROS (Strathearn et al., 2014). 
Interference with the mitochondria, which is responsible for generating energy, 
reduces the overall productivity of the cell as well (Virmani et al., 2013). 
Polyphenols displace rotenone, a mitochondrial complex I inhibitor (Sanders & 
Greenamyre 2013), from its binding site on NADH dehydrogenase, resulting in 
the reduction of ROS produced (Strathearn et al., 2014; Gao et al., 2012). When the 
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levels of ROS are decreased, this reduces the amount of damage caused by 
oxidative stress.  
The brain is particularly susceptible to oxidative stress because of its high 
demand for oxygen (Ataie et al., 2016). Neurons have a high cellular respiration 
rate and low antioxidant defense systems and hence, are highly vulnerable to 
oxidative stress particularly in an aging brain (Cirmi et al., 2016). Antioxidants 
are essential to scavenge free radicals and protect the CNS from further 
degradation (Ataie et al., 2016). Moreover, antioxidants may reverse some of the 
oxidative damage. Antioxidants are electron donors and are able to neutralize 
these ROS without becoming free radicals themselves (Slemmer & Weber, 2014). 
The efficacy of antioxidants comes from their chemical structure, composed of 
one or more aromatic rings with several hydroxyl groups attached. These 
hydroxyl groups trap excess electrons balancing ROS (Pandareesh et al., 2015). 
Certain antioxidants based on their chemical structure, i.e. the number of rings 
and the chemical element that binds them together (Manach et al., 2004), may be 
better at trapping excess electrons and be a stronger antioxidant (Tavares et al., 
2013).  
Polyphenols such as resveratrol, along with scavenging for free radicals, 
potentially stimulate genes that are responsible for the activation of endogenous 
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antioxidant pathways as well (Weber et al., 2012). Furthermore, polyphenols may 
regulate the expression of cellular ROS scavenger enzymes (Tanigawa et al., 
2007). Nuclear factor f2 (Nrf2) is a transcription factor that regulates the gene 
expression of these detoxifying and antioxidant enzymes. A study conducted by 
Tanigawa et al. (2007) showed that the addition of polyphenols, specifically 
quercetin in this study, enhanced the upregulation of Nrf2 mRNA and protein. 
Quercetin was able to reduce the levels of Keap1 which is responsible for 
repressing Nrf2 activation. Polyphenols are also able to reduce cellular ROS 
concentrations through metal ion chelation to help detoxify the CNS (Ataie et al., 
2016; Kelly et al., 2017). The hydroxyl groups within the molecule are the main 
site for metal ion chelation (Bernatoniene & Kopustinskiene, 2018). Detoxification 
through this process helps to minimize cell death and damage.  
1.7.1 Excess Intracellular Ca2+ Levels 
Oxidative stress can have an effect on lipids in the membrane of cells as 
well. Free radicals can build up in the membrane making it faulty (Ataie et al., 
2016; Adibhatla et al., 2007). This results in the cell spilling its contents into the 
surrounding area causing further inflammation and damaging surrounding cells. 
Free radicals that build up in the membrane can also promote permeability to 
Ca2+ (Ataie et al., 2016; Adibhatla et al., 2007), which can cause changes in normal 
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cell function by over-activating Ca2+-dependent enzymes, such as phospholipase 
A2, a precursor to arachidonic acid which is responsible for mediating 
inflammatory responses (Adibhatla et al., 2007). Excess Ca2+ can promote the 
production of free radicals in the cell and other harmful compounds such as 
peroxynitrate and hydrogen peroxide which are highly unstable and can cause 
extensive cellular damage as well as promote oxidative malfunction of the 
mitochondria in cells (Slemmer & Weber, 2014). Increased intracellular levels of 
Ca2+ can activate caspases, which are enzymes responsible for triggering 
apoptosis, and endonucleases which degrade DNA and proteins (Adibhatla et al., 
2007; Vyas et al., 2013), resulting in further cell death and damage. 
1.8 Polyphenols and Apoptosis Activation  
Apoptosis, or programmed cell death, is a well-controlled process that is 
essential for the perpetuation of proper tissue function as it removes unwanted 
and damaged cells (D’Archivio et al., 2008). The apoptotic pathway is 
characterized by a number of morphological changes within the cell. Dysfunction 
within the apoptotic pathway can play a role in NDD. The pathway is activated 
in response to several different agents such as oxidants, toxins, or ionizing 
radiation which can all increase cellular levels of ROS leading to oxidative stress 
(D’Archivio et al., 2008). One of the most important steps in the pathway is the 
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activation of the caspase-3 enzyme which plays a key role in the cleavage of the 
cytoskeleton (Ndozangue-Touriguine et al., 2008). Tumor protein 53 (p53) also 
plays an important role in apoptosis, and is activated in response to DNA 
damage in the cell acting as a pro-apoptotic signal.  
Polyphenols influence different sections of the apoptotic pathway and help 
with the proper steps for shutting down a cell. For example, adding polyphenols 
to carcinogenic cells induces higher rates of apoptosis (Bernatoniene & 
Kopustinskiene, 2018; Curti et al., 2017; D’Archivio et al., 2008). Gupta et al. (2012) 
observed that the addition of polyphenols in prostate cancer cells induced 
apoptosis via p53 stabilization. In contrast, the addition of phenolic compounds 
to brain tissue results in reduced levels of apoptosis. This was shown in a study 
where the addition of polyphenols, mangiferin and morin, resulted in reduction 
of apoptosis by limiting the activation of the N-methyl-D-aspartate 
(NMDA) glutamate receptor responsible for activating caspase-3 neurons in vitro 
and in vivo (Gottlieb et al., 2006; Virmani et al., 2013). NMDA-receptor induced 
toxicity is highly influenced by the influx of Ca2+. Mangiferin and morin were 
able to reduce oxidative stress, and lower Ca2+ concentration which limited 
NMDA glutamate receptor activation and therefore resulted in a decrease in 
caspase-3 activation. Similarly, Bureau et al. (2008) showed that the natural 
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polyphenols, resveratrol and quercetin, significantly decreased mRNA levels of 
pro-inflammatory protein interleukin 1-alpha and tumour necrosis factor alpha 
(TNF-), in glial cells. They observed that the addition of these polyphenols 
reduced apoptotic cell death in neuronal cells induced by microglial activation. 
1.9 Neurodegeneration and Neurodegenerative Disease 
Neurodegeneration is the progressive loss of neuronal structure and 
function and eventual cell death. Neurons do not usually get replaced in the 
adult body, so chronic neurodegeneration can lead to incurable and debilitating 
conditions that cause problems with motor or cognitive functioning. The two 
most common age-related NDD are AD and PD (Balk et al., 2006). NDD are often 
characterized with specific patterns of cell loss in the CNS. One of the main issues 
associated with NDD is that cellular dysfunction often occurs long before onset 
of the actual disease, making it very difficult to implement treatment in the early 
stages which is often the most beneficial (Dauer & Przedborski, 2003). The 
discovery of genes that may increase an individual’s risk of developing a NDD 
has opened the door for research involving dysfunction and misfolding of 
proteins. It is hypothesized that mitochondrial dysfunction and oxidative stress 
play a large part in the accumulation of these insoluble proteins which cause 
extensive damage in the CNS (Dauer & Przedborski, 2003).  
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1.9.1 Alzheimer’s Disease  
Alzheimer’s disease (AD) is a neurodegenerative disease that causes 
irreversible damage to neurons which results in cognitive deficits (Balk et al., 
2006). AD is the most common type of dementia and is not part of normal aging. 
Symptoms associated with AD include disruption to short and long-term 
memory, poor judgement, and difficulty performing basic tasks (Balk et al., 2006). 
The biggest risk factor for the development of AD, like many other NDDs, is age. 
Diagnosis is generally around the mid-60s; however, an individual can only be 
definitively diagnosed at autopsy. As mentioned previously, there are no drugs 
or therapies available to stop the progression of the AD. There are, however, 
drugs available to help treat the symptoms of AD. AD drugs work by regulating 
neurotransmitters, particularly cortical acetylcholine (ACh) (Balk et al., 2006). 
Individuals with dementia usually have lower levels of ACh, which is important 
for the processes of memory, thinking, and reasoning (Richter et al., 1980; 
Scarpini et al., 2003). AD drugs work by increasing ACh production and 
presynaptic release, stimulating cholinergic receptors, such as muscarinic and 
nicotinic receptors, and reducing the degradation of ACh by cholinesterase 
inhibitors. The most common pharmacological drugs prescribed to treat AD are 
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donepezil, rivastigmine and galantamine, which are all acetylcholinesterase 
inhibitors (Scarpini et al., 2003).  
Amyloid-beta and Neurofibrillary Tangles  
The pathological markers associated with the development of AD are 
extracellular amyloid-beta-peptide plaques and intracellular neurofibrillary 
tangles composed of tau protein (Balk et al., 2006). They both cause inclusions in 
the nerve tissue leading to significant neuronal loss (Morales et al., 2014). The 
plaques initially appear between nerve cells in the hippocampus, which is an area 
in the brain involved with the formation of new memories. The tau protein 
tangles are initially deposited in the nerve cells where they interrupt synaptic 
function (Morales et al., 2014).  As the disease progresses, the neurons in the 
hippocampus continue to die which eventually starts to affect other brain areas 
as well, resulting in significant tissue loss throughout the brain (Balk et al., 2006). 
It is important to note that these proteins, particularly amyloid-beta, are also 
highly toxic when in high concentrations and are capable of causing neuronal 
injury and loss even if they are not in an aggregated form (Masliah et al., 2001). 
Mutations in the genes encoding for amyloid-beta precursor protein (APP), and 
presenillin 1 and 2, are associated with the upregulation of cellular proteins and 
products that can be toxic to neurons (Balk et al., 2006). Both mutations are 
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autosomal dominant which means they can be inherited (Singleton et al., 2003), 
although these mutations only account for a very small percentage of AD cases as 
they are highly penetrant. Abnormal cleavage and increased production of APP 
can result in the aggregation and subsequent formation of insoluble amyloid-beta 
plaques which are one of the main pathological markers of AD (Balk et al., 2006). 
Presenillin 1 and 2 are associated with the inheritance of early-onset familial AD. 
It is proposed that amyloid-beta plaques and tau-tangles are able to activate 
microglia, contributing to the inflammatory response which results in the 
overproduction of pro-inflammatory mediators (see section 1.8) (Morales et al., 
2014). Akiyama et al. (2000) showed that there was a higher concentration of 
inflammatory cytokines in the areas surrounding the amyloid-beta plaques and 
tau-tangles.  
Aggregation and dysfunction of amyloid-beta protein is highly influenced 
by issues associated with the mitochondrial electron transport chain, and 
increased levels of ROS in the CNS (Balk et al., 2006). In a study conducted by 
Ono et al. (2012), the addition of phenolic compounds, specifically myricetin and 
rosmarinic acid, inhibited the aggregation of amyloid-beta both in vitro and in 
vivo, as well as reduced cellular cytotoxicity. Similar results were observed by 
Fuentealba et al. (2011), where a neurodegenerative model induced by amyloid-
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beta in vitro was supplemented with a blueberry extract. The addition of the 
blueberry extract was able to protect cells by reducing amyloid-beta protein 
aggregation, and reducing the inflammatory response of nuclear factor kappa B 
(NF-κB), which stimulates the release of inflammatory cytokines in the CNS 
(Pahl, 1999). Furthermore, Papandreou et al. (2012) noted that the addition of 
blueberry extract in vitro was able to reduce amyloid-beta aggregation by up to 
70%.  
1.9.2 Parkinson’s Disease 
Parkinson’s Disease (PD) was first described in 1817 by James Parkinson 
where he referred to it as the “shaking palsy”. PD is caused by neuronal cell 
death in the substantia nigra pars compacta (SNpc) in the midbrain (Braak et al., 
2003). This area is rich in dopamine neurons (DA) neurons which are responsible 
for sending chemical messages to parts of the brain that control movement and 
coordination. As the disease progresses the brain continues to lose DA neurons 
making it difficult for an individual to control their movements (Braak et al., 
2003). With normal aging, you start to lose DA, but PD accelerates this process. 
There is no single cause of PD, most cases are sporadic or idiopathic (Dauer & 
Przedborski, 2003). The biggest risk factor is age; it is rare to see anyone under 
the age of 60 with PD (Balk et al., 2006). Only a very small portion of PD cases are 
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caused by genetic factors. Mutations in genes encoding for alpha-synuclein 
(duplications) and leucine-rich repeat kinase 2 (LRRK2) (multiple point 
mutations; code for a protein called dardarin) can increase an individual’s risk of 
developing PD (Singleton et al., 2003). Both mutations, similarly to those involved 
with AD, are highly penetrant and autosomal dominant. These two mutations are 
the most common, and most penetrant, but there is a long list of other mutations 
that may increase an individual’s risk of developing PD (Singleton et al., 2003).  
There are currently no medications that help with the pathology of PD (i.e. 
depletion of DA neurons in the SNpc) (Dauer & Przedborski, 2003). However, the 
most common drugs available for PD are those that increase DA levels in the 
CNS and ease the motor symptoms such as tremor, rigidity and akinesia. The 
most common pharmacological drugs prescribed to treat PD are levodopa, which 
is a precursor to DA, and ropinirole which mimics DA in the CNS (Grosset, 
2007).  
Alpha-Synuclein and Lewy Bodies  
Alpha-synuclein is a presynaptic protein abundant in the brain, however, 
its function is poorly understood (Strathearn et al., 2014). Disruption to the 
electrons in the mitochondrial electron transport chain and chronic oxidative 
stress (Macedo et al., 2015) promotes the abnormal aggregation of -synuclein 
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(Dauer & Przedborski, 2003; Strathearn et al., 2014). These insoluble aggregates, 
referred to as Lewy Bodies, are associated with extensive neuronal damage and 
death, and are one of the pathological markers contributing to the underlying 
mechanisms associated with PD. When the dopamine-producing cells in the 
SNpc begin to die this gives rise to the movement-related symptoms of PD 
(Strathearn et al., 2014). Alpha-synuclein can contribute to neurodegeneration 
when Lewy Bodies are released from dead or dying neurons, where they can 
activate surrounding microglia and promote the release of inflammatory 
mediators leading to neuroinflammation (Block et al., 2007).  It is impossible to 
measure the presence of Lewy bodies in an individual with PD until that person 
is deceased. However, we can measure their presence with in vitro experiments, 
and in the brains of rodents. Lewy bodies are not exclusive to PD either, they are 
found in the brains of patients with AD and other kinds of dementia. Since its 
discovery, alpha-synuclein has been the focus of intensive efforts to determine 
the protein's role in PD and its potential as a target for neuroprotective therapies.  
Previous studies have determined the effect polyphenols may have on the 
presence of Lewy bodies in the CNS. Both Takahashi et al. (2015) and Macedo et 
al. (2015) showed that the addition of polyphenols lowered cellular ROS levels 
which subsequently reduced cytotoxicity associated with the presence of alpha-
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synuclein in vitro and reduced alpha-synuclein aggregation. Caruana et al. (2011) 
had similar results with the addition of several phenolic compounds, including 
tannic acid found in berry species, to cells in vitro. They observed a reduction in 
the oligomerization of alpha-synuclein and the prevention of further 
neurodegeneration. This is consistent with data showing that the consumption of 
berry extracts with high levels of anthocyanin and proanthocyanin provides 
protection against mitochondrial damage and reduces the risk of PD 
development (Gao et al., 2012). 
1.10 Neuroinflammation 
Neuroinflammation is inflammation of nervous system tissue which can be 
caused from trauma, ischemic stroke, toxic metabolites, chronic oxidative stress 
and prolonged neurodegeneration (Morales et al., 2014). Neuroinflammation is 
believed to be involved in many neurological disorders, including AD and PD. 
An inflammatory response is normally acute in which there is some sort of 
stimulus that promotes the repair of damaged tissue. However, during 
neurodegeneration with AD and PD the stimulus remains persistent over time 
which constantly increases the levels of inflammatory cytokines contributing to 
chronic inflammation in the CNS, as well as increased ROS cytotoxicity (Morales 
et al., 2014; Morales et al., 2016). 
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Microglia are the innate immune cells in the CNS which are activated in 
response to neuroinflammation and are mainly found in the hippocampus and 
the SNpc in individuals with AD or PD (Venneti et al., 2009; Morales et al., 2014). 
They usually remain in a resting state but can be activated by different cues such 
as brain trauma, environmental stimuli, Lewy Bodies (Block et al., 2007), or high 
concentrations of amyloid-beta (soluble and aggregated forms) are present 
(Morales et al., 2014). When microglia become activated they transform 
morphologically and are responsible for regulating brain function and cell 
survival (Block et al., 2007). However, microglia can become over-activated which 
induces the overproduction of compounds that in high levels can become toxic 
and cause extensive damage. For example, inflammatory proteins such as TNF-, 
which is also a marker of microglia activation, can be upregulated and released 
into the surrounding area causing other microglia to become over-activated as 
well, further contributing to neurodegeneration (Morales et al., 2014). Targeting 
these microglia cells is believed to potentially offer new ways to combat 
neurodegenerative diseases.  
Polyphenols are proposed to be able to target and inhibit microglia 
signaling pathways before they become activated and release excess 
inflammatory mediators which in turn could slow down the inflammatory 
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cascade and progression of the disease. The proposed mechanism is that 
polyphenols are able to increase levels of IB, which binds to and inhibits NF-
B, so NF-B remains in the cytoplasm, therefore, preventing the transcription of 
DNA associated with inflammatory mediators (Figueira et al., 2017). Polyphenols 
can inhibit microglia activation via antioxidant scavenging to reduce oxidative 
stress (Morales et al., 2016). A study conducted by Zhu et al. (2008), found that 
blueberry extract significantly reduced amyloid-beta aggregation, enhanced the 
microglial clearance of amyloid-beta, and reduced microglia activation. 
 
Figure 1.4: Neurodegeneration associated with neuroinflammation in the 
central nervous system. 
Adapted from “Neuroinflammation and Neurodegeneration” by Morales et al. 
(2016) and “Neuroinflammation in the pathogenesis of Alzheimer’s disease” by 
Morales et al. (2014).   
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1.11 Glutamate-mediated Excitotoxicity  
Glutamate is an excitatory neurotransmitter, essential for sending electrical 
impulses from one neuron to another. Glutamate-mediated excitotoxicity is a 
pathological process by which cells are damaged and killed by the excessive 
stimulation of glutamate receptors which leads to oxidative stress (Figueira et al., 
2017). This abnormal process can be caused from excessive glutamate release, but 
is mainly influenced by inadequate uptake by glial cells though transporters 
(Gottlieb et al., 2006). When cells are damaged, this results in a loss of ATP which 
inhibits the function of glutamate transporters on glial cells that are essential for 
removing excess glutamate from the extracellular space. Injured and damaged 
neural cells within the lesion site can spill glutamate into the extracellular space 
where glutamate can stimulate presynaptic glutamate receptors to enhance the 
release of additional glutamate.  
Pro-inflammatory stimuli are also thought to provoke the release of 
glutamate by microglia. This can happen over the course of many years, like in 
NDD and brain aging, or very rapidly during TBI or stroke. Recent studies have 
found that glutamate receptors are found on glia in the brain, not just neurons. It 
has been suggested that these receptors may play a role in the activation of 
microglia in inflammation. Microglia are very sensitive to changes in their 
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environment, such as an increase in glutamate. Excess glutamate stimulation to 
glutamate receptors on microglia, can lead to over-activation of microglia 
(Morales et al., 2016). When over-activated the microglia release excess 
inflammatory mediators which over time cause damage to neurons by promoting 
a chronic neuroinflammatory response and increasing cellular levels of ROS. An 
increase in intracellular Ca2+ levels can influence excitotoxicity as well, by causing 
changes in normal cellular processes and over-activating several Ca2+-dependent 







Figure 1.5: Overview of the antioxidant properties and mechanisms associated 
with polyphenols found in blueberry species.  
Adapted from “The Role of Catechins in Cellular Responses to Oxidative Stress” 
by Bernatoniene and Kopustinskiene (2018).  
1.12 Hypothesis  
Considering blueberry extracts contain high levels of phenolic compounds 
which are known to have significant antioxidant activity and free radical 
scavenging ability, I predict that the addition of these extracts to cellular cultures 
in vitro may help combat oxidative stress and neuroinflammation in brain tissue. 
Secondly, I predict that the blueberry extracts will provide significant protection 
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beta toxicity. I predict the blueberry extracts will effectively reduce neuronal and 
microglial cell death, demonstrating that their presence is protective when cell 
death and damage is influenced by glutamate-mediated excitotoxicity, or the 
addition of alpha-synuclein and amyloid-beta protein. 
1.13 Objectives 
The objectives of this research project are: 
• To conduct a biochemical analysis of wild blueberry fruits and leaves from 
four different locations in Newfoundland.  
• To further investigate the potential neuroprotective effects of wild 
blueberry extracts on neurons and glial cells exposed to glutamate, alpha-
synuclein, and amyloid-beta in vitro.  
• To determine the palatability of a berry-enriched diet over the course of 5-
weeks in a mouse model 
• To perform a pilot study to determine the effects of wild blueberry extracts 








Chapter 2: Methods and Materials 
2.1 Plant collection and storage  
Lowbush wild blueberries, Vaccinium angustifolium, were collected from two 
different locations in central St. John’s, including two samples from Pippy Park 
and one Fort Amherst sample, as well as one sample from Keels, located in 
northcentral Newfoundland. Both blueberry fruits and leaves were collected 
from these locations in September 2016. After collection, the samples were 
immediately placed into a cooler with icepacks, then put into a -20°C freezer 
within 1.5 hours of collection and later transferred to a -80°C freezer within 24-
hours.  
2.2 Blueberry fruit and leaf extraction 
2.2.1 Fruit extraction  
Solvent was prepared consisting of 80% (v/v) acetone, 0.2% formic acid, 
and 19.8% distilled water (dH2O). Blueberry fruits were removed from the -80°C 
freezer and thawed at room temperature (~20°C). Debris, such as vines and dirt 
were removed, as well as extensively damaged berries. The blueberry fruits were 
placed in a mortar and pestle and mashed. Weight was measured, and then 
solvent was added to dilute the ground blueberry fruits to a concentration of 1:2. 
The solution was then mixed by vortex for 20 seconds, placed in a cooler with ice 
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and shaken for 30 minutes. The solution was then centrifuged at 4°C for 20 
minutes at 10 000 G (gravitational force). Supernatant was then drained in a 
separate container, and the whole procedure was repeated using the remaining 
residue. The final concentration was 250 mg/ml solvent of fresh weight, which is 
the weight of the specimen including its water content.  
 Leaf extraction  
Healthy green leaves were selected, removed from their vines, and placed 
in a mortar and pestle. Liquid nitrogen was slowly added to the blueberry leaves 
with constant stirring. This helped with the breakdown of cellulose resulting in 
the leaves turning into a fine dry powder. Then the solvent was added to the 
powdered blueberry leaves at a concentration of 1:2. The solution was mixed by 
vortex for 20 seconds, placed in a cooler with ice and shaken for 30 minutes. The 
solution was then centrifuged at 4°C for 20 minutes at 10 000 G. Supernatant was 
drained in a separate container, and the whole procedure was repeated using the 
remaining residue. The final concentration was 250 mg/ml solvent of fresh 
weight, which is the weight of the specimen including its water content.  
2.3 Biochemical assays  
All stock blueberry fruit and leaf extracts were used for the biochemical 
assays within one week of extraction, and all experiments were repeated three 
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times for each assay. All assays followed the same methods as Vyas et al. (2013). 
Further dilution was necessary for the stock extracts at 1:10 (stock:solvent) for the 
fruit and 1:100 for the leaves, to a final concentration of 25 mg/ml of fruit and 2.5 
mg/ml of leaf fresh weight. Distilled H2O was used for the blank and used to 
rinse out the quartz cubes between samples. 
 Total antioxidant capacity  
Total antioxidant capacity was determined using the 2, 2-diphenyl-1-
picrylhydrazyl (DPPH) assay, which is a stable free radical. DPPH is violet in 
colour, but when it is neutralized a colourimetric reaction occurs that makes the 
solution lighter in colour. This method allows for the quantification of free 
radical scavenging ability of the sample, as antioxidants are able to neutralize the 
radical DPPH. The method was adapted from Vyas et al. (2013), and Brand-
Williams et al. (1995), where 100 μl of blueberry extract was added to 1.9 mL of 
0.04 mM stock DPPH. The solution was then mixed by vortex for 20 seconds, 
protected from light for 20 minutes and measured with the spectrometer at 517 
nm. Total antioxidant capacity was expressed as ‘% of inhibition of DPPH 
consumption’, and the results were expressed as ‘Gallic Acid Equivalents’ (GAE) 
using the Gallic acid standard curve.  
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 Total phenolic content  
In order to determine the total phenolic content of the blueberry fruit and 
leaf extracts, Folin-Ciocalteu reagent was used. The method for this assay was 
adapted from Chandrasekara and Shahidi (2011). Folin-Ciocalteu is a redox 
reagent that is blue in colour; the higher the phenolic content the darker the blue. 
0.5 mL of blueberry extract was added to 0.5 mL of Folin-Ciocalteu reagent. Then, 
1 mL of sodium carbonate (Na2CO3; 25 g of Na2CO3 into 250 mL dH2O) and 8 mL 
of dH2O was added to the solution and mixed by vortex for 30 seconds. The 
solution was protected from light for 35 minutes, and then centrifuged at room 
temperature for 10 minutes at 1000 G. Absorbance was measured at 725 nm using 
the spectrometer. Total phenolic content was then determined using a Gallic acid 
standard curve, and the results were expressed as milligrams of GAE per gram of 
fresh weight. 
 Total flavonoid content  
The method was adapted from Zhishen et al. (1999), and the results were 
expressed as μmol of catechin equivalents (CE) per gram of sample. To determine 
the total flavonoid content of the samples, 1 mL of extract was added to 4 mL of 
dH2O, and 0.3 mL of 5% sodium nitrite (NaNO2) and left to sit for 5 minutes. 
Then, 0.3 mL of 10% aluminum chloride (AlCl3) was added, and one minute later 
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2 mL of sodium hydroxide (NaOH) and 24 mL of dH2O was mixed in. The 
solution was protected from light for 15 minutes, and then centrifuged at room 
temperature for 4 minutes at 4000 G. The solution was measured at 510 nm with 
the spectrometer. 
 Total tannin content  
Total tannin content was determined using vanillin-hydrogen chloride reagent 
(0.5 g of vanillin added to 96 mL methanol [MeOH], plus 4 mL of HCl). For this 
assay, 1 mL of blueberry extract was added to 5 mL of 9.5% vanillin-HCl reagent 
and the resulting colourimetric reaction produced a bright red colour. The 
solution was then incubated and protected from light for 20 minutes and the 
absorbance was measured at 500 nm using the spectrometer. The results were 
expressed as micromoles (μmol) of CE per gram of sample. The method for total 
tannin content was adapted from Chandrasekara and Shahidi (2011). 
 Total anthocyanin content 
This assay required two solutions:  
i. Potassium chloride buffer  
1.86 g KCl + 980 mL dH2O → pH=1, 0.025 M 
ii. Sodium acetate buffer 
54.43 g NaCO2CH3 + 3 dH2O → pH=4.5, 0.4 M 
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The two solutions were mixed together and incubated at room temperature for 40 
minutes. 1 mL of blueberry extract was added to 4 mL of KCl/NaCO2CH3 buffer 
for a total volume of 5 mL, and placed in the dark for 15 minutes. The absorbance 
was measured at both 510 nm and 700 nm using the spectrometer. The corrected 
absorbance result was calculated as ([A520 – A700] pH=1.0 – [A520 – A700] 
pH=4.5). The method was adapted from Foley and Debnath (2007), and the 
results are expressed as GAE 
2.4 Cell culture experiments  
For the cell culture experiments the Pippy Park (2/09/16) blueberry fruit 
sample was used. This was determined based on the high quantity and quality of 
this sample, as it contained the highest total antioxidant activity compared to 
samples from the other locations. Samples from Pippy Park (2014) were selected 
for previous studies in our lab where high-performance liquid chromatography-
mass spectrometry (HPLC-MS) was performed. All chemicals and reagents used 
for cell culturing were filtered through a syringe or bottle filter to ensure sterility, 
and 70% ethanol was used as the disinfectant. All steps for the cell culture 
experiments were conducted under a biosafety cabinet, with exception of the 
actual dissection, and media was always placed in a water bath at 37°C for 10 
minutes before the media was changed. Mixed cultures of neurons and glia were 
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produced from dissected C57BL/6 strain mouse-pup cortical brain tissue, while 
pure cultures of either cortical neurons or microglia were purchased from a 
commercial source (ScienCell Research Laboratories, Carlsbad, CA). Mixed 
cultures were used to represent the conditions present in the brain where both 
neurons and many different types of glia reside and can influence the 
concentration of excess glutamate, alpha-synuclein, and amyloid-beta. Pure 
cultures of neurons and microglia were purchased because the breeding pairs 
from our colony were not producing enough pups for us to produce our own 
pure cultures at an adequate level. Pure cultures of microglia and neurons 
allowed us to determine the direct effect the addition of glutamate and high 
concentrations of alpha-synuclein and amyloid-beta had on specific cell types. 
The sensitivities could then be analyzed among the cell types to see how 
microglia and neurons specifically reacted to glutamate, alpha-synuclein, or 
amyloid-beta. Mouse-derived neurons and microglia were not available from 
ScienCell when the experiments were being conducted so rat cultures were used 
instead.  
 Dissection plates  
The animals used for the dissection process were C57BL/6 mouse pups 
aged one to three days old. They were from breeding pairs located in our mouse 
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lab colony in the Health Sciences Centre (HSC) Animal Care facility. All 
protocols and procedures were approved by the Institutional Animal Care 
Committee (IACC) of Memorial University of Newfoundland (MUN). Twenty-
four hours prior to the dissection, 24-well Costar® culture plates or 16-well glass 
chamber slides were coated with 500 μg/mL poly-L-ornthine (PLO) solution to 
ensure cell adherence to the flat bottom wells. PLO solution was prepared by 
dissolving 100 mg of PLO in 10 mL of dH2O, which was then aliquoted into 1.5 
mL centrifuge tubes, with 300 μL per tube and stored at -80°C. These aliquots 
were diluted before plating by mixing 5.7 mL dH2O to the 300 μL aliquot, 
resulting in a PLO concentration of 500 μg/mL. For the Costar® plates each well 
received 250 μL of PLO and the 16-well glass slides received 100 μL of PLO per 
well. Plates were then incubated overnight at 37°C and 5% carbon dioxide (CO2). 
In the morning of the dissection each well was washed twice with dH2O before 
cells were plated.  
Dissection procedure:  
All tools were first rinsed in 70% ethanol. Two small petri dishes and two 
15 mL test tubes were placed on ice and filled with 10 mL dissection media, 
which consisted of 100 mL of Hank’s Buffered Salt Solution (HBSS) and 1 mL 
penicillin/streptomycin (PenStrep). The mouse-pup was quickly decapitated with 
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large scissors, and the body discarded. The skin on the skull was cut posterior to 
anterior using small scissors. A lateral cut was made by going into the foramen 
magnum on both sides of the skull and cutting towards the front of the head. The 
skin was then peeled back, where the skull was visible and then cut medially. 
The brain was carefully removed and then placed in a petri dish with ice cold 
dissection media. A scalpel was used to remove the cerebellum, before using a 
dissection scope to carefully remove the meninges with fine forceps. The whole 
brain (minus the cerebellum) was then placed in one of the 15 mL tubes 
containing fresh dissection media.  
 The tissue was then washed by centrifuge at 1000 revolutions per minute 
(rpm) at 4°C for 3 minutes. Supernatant was removed, and replaced with 10 mL 
of fresh dissection media, and washed again with the same conditions as above. 
Supernatant was removed, and replaced with 0.8 mL of 0.25% Trypsin-EDTA 
(see Table 2.1) diluted in 9.2 mL fresh dissection media, and incubated at 37°C for 
15 minutes. Supernatant was again discarded and the tissue was washed with 10 
mL growth media at 1200 rpm at 4°C for 5 minutes. Cells were triturated with 4 
mL fresh growth media using a 10 mL pipette, and then a 100 μL pipette tip once 
large aggregates were broken down. The solution was filtered through a 70 nm 
nylon strainer into a 50 mL test tube, and diluted with growth media for a total 
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volume of 12 mL. For the 24-well Costar® plates each well received 250 μL of 
solution and for the 16-well glass slides, each well received 100 μL. Plates were 
then incubated at 37°C and 5% carbon dioxide (CO2) for 10 to 16 days. The plates 
were undisturbed for 24-hours after initial plating, followed by a complete media 
change. This entailed drawing off all of the dead cells and adding 500 μL fresh 
culture media to the Costar® plates and 150 μL for the 16-well glass slides. 
Subsequently, the media was changed every 2 to 3 days, where 90% of the media 
was drawn from each well and then replaced with fresh culture media. For the 
Costar® plates 450 μL was drawn from each well and 500 μL of fresh culture 
media added. For the 16-well glass slides 135 μL was taken out and 150 μL fresh 
culture media was added to the wells.  
Table 2.1: List of chemicals and reagents used for cultured cells. 
Chemical/Reagent  Recipe 
Dissection media 100 mL HBSS + 1 mL 
PenStrep 
0.1% Trypsin-EDTA Solution 100 mL Trypsin-EDTA + 100 
mL HBSS + 1 mL PenStrep 
32.5% Glucose Solution  32.5 g Glucose + 67.5 mL 
dH2O 
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Sodium Pyruvate Solution 550 mg Sodium pyruvate + 50 
mL dH2O 
Growth Media  500 mL sterile basal medium 
+ 5 mL PenStrep + 8 mL 
32.5% glucose solution + 5 
mL sodium pyruvate + 5 mL 
N2 supplements + 5 mL 
amphotericin B + 50 mL horse 
serum  
Culture Media  500 mL sterile basal medium 
+ 5 mL PenStrep + 8 mL 
32.5% glucose solution + 5 
mL sodium pyruvate + 5 mL 
N2 supplements + 10 mL B27 
supplements  
 
 Rat neuron plates  
Neurons were purchased from ScienCell Research Laboratories (Carlsbad, 
CA, USA) which were isolated from postnatal day 2 CD® IGS rat brains, 
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cryopreserved after purification and frozen at -80°C prior to use. Plates were 
incubated at 37°C overnight with 500 μg/mL PLO solution. Specific neuronal 
medium (ScienCell) was prepared at our lab, which consisted of 500 mL sterile 
neuronal medium, 5 mL Neuronal Growth Supplement, and 5 mL of 
penicillin/streptomycin solution stored at 4°C. The optimal growth period for the 
ScienCell rat neurons was 7-10 days. Each vial contains >1 x 106 cells in 1 mL 
volume, with an optimal density between 20,000-25,000 cells/cm2: 
• Total µL of cells/number of wells= X µL per well 
X µL per well/SA of well= cells/cm2 (density) 
• With 24-well Costar® plates well SA=1.9 cm2, results in ~41,700 cells per 
well per plate and 21,929 cells/cm2 with 1 mL of media  
• With 16-well glass slides well SA=0.4 cm2, results in ~8928 cells per well 
and 22,321 cells/cm2 with 200 µL of media  
 Rat microglia plates  
Microglia were purchased from ScienCell Research Laboratories 
(Carlsbad, CA, USA) which were isolated from postnatal day 2 CD® IGS rat 
brains, cryopreserved after purification and frozen at -80°C prior to use. Specific 
microglia medium (ScienCell) was prepared at our lab, which consisted of 500 
mL of sterile microglia medium, 5 mL of penicillin/streptomycin solution, 25 mL 
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fetal bovine serum, and 5 mL Microglia Growth Supplement stored at 4°C. The 
optimal growth period for the ScienCell rat microglia was 3 to 6 days. The rat 
microglia were plated with the same densities as the ScienCell neurons, however 
PLO was not used for the microglia plates, as previous studies in our lab found 
adequate adherence of microglia without the application of PLO.  
 Cell treatments  
Once cells were plated and started to differentiate during their optimal 
growth (10 to 16 days for dissection plates; 7 to 10 days for ScienCell rat neurons; 
3 to 6 days for ScienCell rat microglia) the cells were given a particular treatment 
and then placed back into the incubator at 5% CO2 and 37°C for 24-hours. After 
treatment, the cells were then fixed, stained, and analyzed. Stock solutions of 
glutamate, alpha-synuclein, amyloid-beta and berry extract were produced, 
aliquoted, sterilized, and stored in a -80°C freezer. The control treatment was 
composed of 10 µL sterile dH2O/ mL of media.  
Aqueous Berry:   
 This stock was made by thawing 10 to 20 frozen blueberry fruits from the 
Pippy Park (2/09/16) sample at room temperature and then mashing them in a 
mortar and pestle. The mixture was filtered through a 70 nm nylon strainer into a 
50 mL test tube, sterilized, aliquoted in 1.5 mL centrifuge tubes, and stored in a    
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-20°C freezer. This solution was used alone, to see if the extract had any effect on 
the viability of cells, or with glutamate, alpha-synuclein, or amyloid-beta to see if 
the extract provided any cellular protection. This concentration was previously 
determined by the research group to be the optimal concentration to elicit a 
neuroprotective effect. 
• 1 µL blueberry extract stock/ mL of media 
Glutamate:  
A stock solution of 10 mM glutamate was made, where 10 ml of sterile dH2O 
was added to 14.7 mg of L-glutamic acid (Research Biochemicals Inc.) and sterile 
filtered. This concentration was previously determined by our lab to be the 
optimal glutamate concentration causing neuro-inflammation.  
• 10 µL of 10 mM glutamate stock/ mL of media for a final concentration of 
100 µM glutamate  
Glutamate + aqueous berry:  
• 10 µL of 10 mM glutamate stock/ mL of media for a final concentration of 
100 µM glutamate  





A stock solution of alpha-synuclein was made by dissolving 100 μg/ml of 
alpha-synuclein into 5 mL of dH2O. This concentration was previously 
determined by our lab to be the optimal alpha-synuclein concentration causing 
neuro-inflammation. 
• 1 µL alpha-synuclein stock/ mL of media for a final concentration of 100 
ng/mL alpha-synuclein 
Alpha-synuclein + aqueous berry: 
• 1 µL alpha-synuclein stock/ mL of media for a final concentration of 100 
ng/mL alpha-synuclein 
• 1 µL blueberry extract stock/ mL of media 
Amyloid-beta: 
Amyloid-beta (rPeptide®) from recombinant DNA encoding for the 
human beta-amyloid sequence (1-42) expressed in E. coil, was prepared by first 
diluting 0.5 mg of amyloid-beta in 0.5 mL of 1% ammonium hydroxide (NH4OH) 
to a stock concentration of 221 µM. This solution was then sonicated for 1 minute. 
The second dilution was with cell culture media when amyloid-beta was put into 
the individual wells to achieve a final concentration of 7.5 µM as described by 
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Nafar and Mearow (2014). The solution was then sterilized with a syringe filter, 
aliquoted in 1.5 mL centrifuge tubes and stored in a -80°C freezer. 
• 33.86 µL amyloid-beta stock/ mL of media for a final concentration of 7.5 
µM amyloid-beta 
Amyloid-beta + aqueous berry: 
• 33.86 µL amyloid-beta stock/ mL of media for a final concentration of 7.5 
µM amyloid-beta 
• 1 µL blueberry extract stock/ mL of media 
2.5 Immunohistochemistry and imaging  
After 24-hours of treatment the cells were fixed and then labeled/stained. 
Media was removed from each well and put into a 1.5 mL centrifuge tube. The 
tube was then dipped in liquid nitrogen for 30 seconds and immediately put into 
a -80°C freezer. The following steps use 250 µL of reagent for the 24-well plates 
and 150 µL of reagent for the 16-well glass slides unless otherwise specified.  
Once the media was removed the wells were washed twice with 
Phosphate Buffer Solution (PBS), and fixed for 20 minutes with 4% 
Paraformaldehyde Fixative (PFA), cultures were then permeabilized with 0.2% 
Triton X for 10 minutes, and washed twice with PBS.  
 
 50 
Table 2.2: Chemicals and reagents used for staining and fixing cultured cells. 
Chemical/Reagent  Recipe  
Phosphate Buffer Solution 
(PBS) 
 
500 mL 0.2 M phosphate 
buffer + 500 mL dH2O + 9 g 




400 mL dH2O raised to 70°C 
+ 40 g paraformaldehyde + 
10 drops of sodium 
hydroxide added slowly + 
500 mL 0.2 M PBS + dH2O 
until total volume reaches 
1000 mL  
0.2% Triton X 2 mL 10% Triton X + 98 mL 
PBS 
Blocking Solution  2g 2% bovine serium 
albumin + 2 mL 2% fetal calf 
serum + 200mg 0.2% fish skin 
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gelatin + 98 mL PBS + mixed 
with heat  
 
 Labeling and staining of cells 
After the fixing procedure the cultured cells were labeled with antibody 
(Ab) solutions. First the cultures were incubated with blocking solution for 30 
minutes to inhibit non-specific binding, and then incubated for 1 hour with 
primary antibody diluted with PBS (90%) and blocking solution (10%). After the 
incubation period the wells were washed twice with PBS, and then incubated for 
an hour with the appropriate secondary antibody diluted with PBS (90%) and 
blocking solution (10%). 
Table 2.3: Primary and secondary antibodies used for labeling and their 
concentrations. 
Primary Antibodies: Secondary Antibodies:  
Neurons:  
• Microtubule-associated 
protein 2 (MAP-2) Ab 
(1:500) 
• Neuronal nuclei (NeuN) Ab 
(1:500) 
Microglia 
• Alexa 488 goat anti-mouse 
(green; 1:300) 
• Alexa 488 goat anti-rabbit 
(green; 1:300) 
• Alexa 488 goat anti-rat 
(green; 1:200) 
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• IbA-1 Ab (1:500) 
Astrocytes 
• Glial fibrillary acidic protein 
(GFAP) Ab (1:500) 
Apoptosis 
• Caspase 3 Ab (1:1000) 




After labeling with the secondary Ab the cultures were washed twice with 
PBS, and the wells were then dehydrated with 70% ethanol, followed by further 
dehydration with 100% ethanol. Once each well dried completely, 10 μl of 
VectaShield mounting medium with the fluorescent stain 4', 6-diamidino-2-
phenylindole (DAPI) was added to all the Costar® wells and then sealed with a 
15 mm glass coverslip. This stain is able to pass through an intact cell membrane 
and therefore labels the nucleus of both live and fixed cells. For the 16-well glass 
slides once fixing was finished, the plastic well chambers were snapped off and a 
scalpel was used to scrape off the remaining silicon on the glass slide. 
Approximately 5 to 8 μl of VectaShield was added to the slide where each well 
used to be, and the slide was completely covered with one glass coverslip. Clear 
nail polish was put around the edges to ensure the coverslip was stuck in place 
and prevented the slide from drying out. All plates and slides were wrapped in 
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tinfoil to protect the fluorescence from light, stored in a -20°C freezer and then 
imaged within a few days.  
 Imaging 
All Costar® cell culture images were captured with a Zeiss A1 Observer 
inverted microscope with a PCO.Pixelfly qe CCD camera at a magnification of 
40X using AxioVision and PCO Camware software. A total of five images were 
taken from separate locations in each well, then cells were counted manually by 
two individuals and the counts were averaged. The 16-well glass slides were 
imaged by Dr. Noriko Daneshtalab using an inverted Olympus Fluoview FV 
1000 confocal microscope at 40X, 3.5x zoom, and 65 to 79% light intensity for 
DAPI and Alexa 488 fluorescence.  
 
Figure 2.1: Zeiss Axio Observer. A1 microscope, Sensicam PCO. Pixelfly 
V1.101.0 qe CCD camera connected to AxioVision and PCO. Camware software. 
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 Apoptotic counts  
Apoptotic counts were conducted manually for the cell culture plates, 
however, due to calibration issues with the Sensicam PCO. Pixelfly camera the 
counts were not reliable or consistent and are therefore not included. Images 
were not of sufficient quality to reliably determine if cells were potentially 
apoptotic.  
2.6 Pilot blueberry diet study  
This study was conducted in August to September of 2017, and took place 
over 34 days (start date: Aug 8, 2017; end date: Sept 11, 2017). This diet study was 
mainly to determine the palatability of using a blueberry and pellet-powder 
“mash” over an extended period of time. Up until this point other research 
groups, including our own, mostly focused on oral gavage for administration of a 
special diet (Atcha et al., 2010; Grace et al., 2009; El-Mohsen et al., 2006). This 
method can be very invasive and has been shown to induce significant stress in 
the animal, including increased plasma concentrations of corticosterone, glucose, 
growth hormone, and prolactin (Balcombe et al. 2004). As behavioral experiments 
were being conducted during the study it was important to minimize stress that 
could confound the results. The animals were able to freely eat the mash just as 
they would freely eat their regular pellets, which minimized stress and the 
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potential for severe internal damage. Oral gavage when not conducted by 
someone highly experienced can cause extensive throat and oral damage, lung 
perforation and aspiration, and restraint-associated injuries (Vandenberg et al. 
2014). Also, oral gavage bypasses the oral and esophageal mucosa and epithelia 
which can lead to potential differences with the absorption, breakdown of 
metabolites and bioavailability of the compounds of interest.  
There were 18 C57BL/6 mice used in this study from our breeding colony in 
the HSC Animal Care facility at MUN. All protocols and procedures were 
approved by the IACC MUN. Conditions included a standard 12-hour light and 
12-hour dark cycle. There were two groups, nine animals in each consisting of a 
control group and an experimental group that received the berry-enriched diet. 
The animals in the colony were both male and female and varied in age. The 
animals were assigned to a group by a member of the lab not involved in the 
study, based on these characteristics and not their starting body weight or 
performance during rotarod training (see Table 2.4 below). Animals were housed 
individually overnight when the control or blueberry-enriched diet was 
presented to them. During the day, any animals that were housed together were 
put back into a single cage (1-3 animals) to socialize in hopes to reduce anxiety 
and depression-like behaviors (Martin & Brown 2010). The main focus of this 
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study was to ensure that the mice would voluntarily eat the prepared mash, and 
ensure that there were no weight fluctuations or overt behavioral changes 
associated with its consumption.  
Table 2.4: Age and sex of control and experimental C57BL/6 wild type mice 
used in palatability diet study. 
Subject 
Number 
Condition Birthday Age Sex 
1 Control 23-Feb-17 <6mo-≦3mo M 
2 Control 26-Jan-17 ≧6mo M 
3 Control 26-Jan-17 ≧6mo M 
4 Control 03-Apr-17 <6mo-≦3mo F 
5 Control 03-Apr-17 <6mo-≦3mo F 
6 DIED FROM SEZIURE DAY 10 F 
7 Control 12-Jun-17 <3mo F 
8 Control 03-Apr-17 <6mo-≦3mo M 
9 Control 03-Apr-17 <6mo-≦3mo M 
1 Experimental 26-Jan-17 ≧6mo F 
2 Experimental 26-Jan-17 ≧6mo F 
3 Experimental 03-Apr-17 <6mo-≦3mo M 
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4 Experimental 03-Apr-17 <6mo-≦3mo M 
5 Experimental 12-Jun-17 <3mo F 
6 Experimental 12-Jun-17 <3mo F 
7 Experimental 26-Jan-16 ≧6mo M 
8 Experimental 26-Jan-17 ≧6mo M 
9 Experimental 03-Apr-17 <6mo-≦3mo F 
 
 Preparation of mouse feed with blueberry extract 
Fresh mash was made daily in the afternoon from frozen Pippy Park 
(2/09/16) blueberry fruits that were stored in -80°C and then thawed at room 
temperature. The berries were mashed in a mortar and pestle until they were 
grinded into a liquid state, including all parts of the berry (i.e. skins, seeds). The 
normal pellets given to the mice in the animal care facility at MUN were then 
ground into a very fine powder and mixed with distilled water at 1:1 (eg. 50 g of 
powder: 50 mL of dH2O). Each mouse in the experiment was given 5 g of mash 
every day (Bachmanov et al. 2004). The control group just received mash that 
consisted of the pellet powder mixed with dH2O as the solvent. For the 
experimental group 0.1 g (2% of 5 g) of the grinded blueberries were measured 
and then mixed directly with 5g of the mash. The mash was presented to both 
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groups in a small petri dish, which were labeled and washed daily and the mice 
were always given access to water. For the blueberry-enriched diet, 2% fruit 
extract was chosen based on previous studies including Andres-Lacueva et al. 
(2005) and Kalt et al. (2008) where 2% berry extract yielded the best results.  
 Daily procedures  
Every day the mice were weighed in the morning, and those housed 
together before the experiment began were allowed to spend some time together 
in the same cage, if they were in the same group. At this time, regular food 
pellets from Animal Care were returned to the cages and any tests, such as 
rotarod or novel object recognition were performed. Later in the afternoon the 
animals were placed back in their individual cages for the night and the pellets 
were removed from the cage. The mice were then given the control mash, or the 
2% blueberry mash. The next morning, the empty dishes that held the mash were 
removed during weighing.   
 Rotarod 
The rotarod is a tool used to measure motor coordination, balance, and 
endurance of an animal by measuring how long they are able to stay on a 
rotating rod. The animal will try to avoid falling off of the rod as best they can, 
but the rod is not high enough to harm the animal even if they do fall off. 
 59 
Training was conducted over the course of three days where animals were 
acclimated to the process of rotarod testing and were placed on the rotarod at 
4rpm for 5 minutes. Training was conducted on August 1 to 3 2017, five days 
before the beginning of the diet study. For this study, fixed-speed rotarod testing 
was used where the rod was set at a constant speed, either 5 rpm, 10 rpm, or 15 
rpm without acceleration for 120 seconds. Once the animal was securely on the 
rotating rod, the timer was set and would continue until the animal fell and 
triggered the time-stop or was able to stay on the rod for the full 120 seconds. All 
animals were tested 3x at each fixed speed (5 rpm, 10 rpm and 15 rpm) during 
each session. Rotarod testing was performed twice a week, with a total of 8 
sessions over the duration of the study.  
 Novel Object Recognition  
Novel object recognition (NOR) is used to assess non-spatial memory. The 
mice were first habituated to the box for 5 minutes on two days prior to testing, 
there were no objects in the box at this time. On test day, the mice were placed 
into the box with two identical objects for 5 minutes (AA or BB). An hour later 
mice were placed back in the box with the familiar object and a novel object (A/B) 
for five minutes. Then, 24-hours later, the mice were placed back in the box with 
the familiar object and novel object (A/B) for five minutes. The videos were 
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scored based on the animals exploration of the novel object, exploration of the 
familiar object, total exploration time and discrimination index ([exploration of 
novel - exploration of familiar]/[total exploration time]). When the discrimination 
index (DI) is greater than zero it indicates that the animal explored the novel 
object more than the familiar object and retained a memory of the familiar object 
(as delay is increased memory retention should become more difficult). Videos 
were scored by two individuals and reliability statistics were determined. 
 Blood collection  
Blood was collected from three subjects from each of the groups halfway 
through the study (week of August 21st, 2017), however, there were insufficient 
amounts to conduct any analysis and were therefore discarded. Further attempts 
were not made in order minimize any stress for the animals considering the small 
sample size.  
 Brain collection  
All brains from the mice in the pilot diet study (except for control 6) were 
collected at the end of the study. Animals were placed into a container where a 
small amount of halothane/isoflurane was present for about 1 minute. 
Anesthetization was confirmed when there was no blink reflex after lightly 
touching the animals eye. Mice were then decapitated using an animal guillotine 
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and brains were collected (see cell culture dissection procedure). The brains were 
then dipped in liquid nitrogen for 1 minute, placed in a 15 mL test tube, and 
stored in a -80°C freezer. Samples are currently awaiting analysis.  
2.7 Statistical analysis  
For the biochemical analysis of the blueberry samples from Pippy Park, Fort 
Amherst, and Keels, each experiment was repeated three times and statistically 
significant results between the blueberry fruits and leaves for the samples were 
determined via two-way ANOVA and post hoc Bonferroni test (p<0.05) using 
GraphPad: Prism-7, data represented as mean ± standard error (SE). Significant 
differences between the fruits from the four samples were determined via one-
way ANOVA and post hoc Tukeys test (p<0.05) using SPSS-39, data represented 
as mean ± SE. Significant differences between the leaves from the four samples 
were determined via one-way ANOVA and post hoc Tukeys test (p<0.05) using 
SPSS-39, data represented as mean ± SE. For the cell culture experiments, 
statistically significant results between the different treatment conditions was 
determined via one-way ANOVA and post hoc Tukeys test (p<0.05) using 
GraphPad: Prism-7, data represented as mean ± SE. Weight, rotarod, and NOR 
results for the diet study including differences between the control and 
experimental group were analyzed via two-way ANOVA and post hoc Bonferroni 
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test (p<0.05) using GraphPad: Prism-7, data represented as mean ± SE. For the 
NOR testing, reliability statistics were also conducted for the NOR video scoring 
using Cronbach’s Alpha in SPSS-39. Cronbach’s Alpha measures consistency and 














Chapter 3: Results  
3.1 Biochemical Assays 
Figures 3.1 to 3.15 show the results of biochemical assays conducted for 
blueberry fruits and leaf samples from Pippy Park (2/09/16) and (21/09/16), Keels 
(17/09/17), and Fort Amherst (25/08/17). Overall, the leaves were higher for total 
antioxidant activity (Figure 3.1), total phenolic content (Figure 3.4), and total 
flavonoid content (Figure 3.7). Total anthocyanin content (Figure 3.13) was the 
exception where the fruits were significantly higher than the leaves. Total tannin 
content (Figure 3.10) had mixed results where both Pippy Park samples had 
higher anthocyanin levels in the leaves, and Keels and Ft. Amherst had higher 
levels in the fruits. Even though the locations were geographically close together, 
there were significant differences between the different samples for both fruit 
and leaves which varied based on the assay. All biochemical assays were 
repeated three times for each sample, and all samples were collected in 2016. 
Significant differences between the fruits and leaves of the sample were 
determined via two-way ANOVA and post hoc Bonferroni test (p<0.05), 
represented as 0.033(*), 0.002 (**), and <0.0001(***). Significant differences 
between the fruits from the four samples and the leaves from the four samples 
were determined via one-way ANOVA and post hoc Tukeys test (p<0.05). 
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Different letters (a, b, c, d) indicate statistical significance between locations at 
p<0.05.  
3.1.1 Total antioxidant activity  
 
Figure 3.1: Total antioxidant activity of blueberry fruit vs leaf extracts. 
Significant differences between the fruits and leaves of the sample were 
determined via two-way ANOVA and post hoc Bonferroni test (p<0.05), 
represented as 0.033(*), 0.002 (**), and <0.0001(***). Significant difference between 
the fruits and the leaves are observed for all four locations, where leaves had a 
higher total antioxidant activity than the fruits (p=<0.0001, DF=16). Leaves from 
Pippy Park (2/09/16) and fruits from Keels had the highest total antioxidant 
activity. The data are expressed as the mean ± SE. 
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Figure 3.2: Total antioxidant activity of the blueberry fruit extracts. 
Significant differences between the fruits from the four samples were 
determined via one-way ANOVA and post hoc Tukeys test (p<0.05). Significant 
differences for the total antioxidant activity of the fruits are between the Pippy 
Park samples and Keels, and the Pippy Park samples and Ft. Amherst (p=<0.0001, 
DF=11). Values represented by the same letter indicate there are no significant 
differences within samples from those locations. The data are expressed as the 
mean ± SE, and are represented in Figure 3.1. 
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Figure 3.3: Total antioxidant activity of the blueberry leaf extracts. 
Significant differences between the leaves from the four samples were 
determined via one-way ANOVA and post hoc Tukeys test (p<0.05). Significant 
differences for the total antioxidant activity of the leaves are between all four 
samples (p=<0.0001, DF=11). Values represented by the same letter indicate there 
are no significant differences within samples from those locations. The data are 
expressed as the mean ± SE, and are represented in Figure 3.1.  
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3.1.2 Total phenolic content 
 
Figure 3.4: Total phenolic content of blueberry fruit vs leaf extracts. 
Significant differences between the fruits and leaves of the sample were 
determined via two-way ANOVA and post hoc Bonferroni test (p<0.05), 
represented as 0.033(*), 0.002 (**), and <0.0001(***). There is a significant 
difference between the fruits and the leaves observed for all four locations where 
leaves had a higher total phenolic content than the fruits (p=<0.0001, DF=16). 
Leaves from Ft. Amherst and fruits from Pippy Park (21/09/16) had the highest 
total phenolic content. The data are expressed as the mean ± SE.  
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Figure 3.5: Total phenolic content of the blueberry fruit extracts. 
Significant differences between the fruits from the four samples were 
determined via one-way ANOVA and post hoc Tukeys test (p<0.05). Significant 
differences for the total phenolic content of the fruits are between Pippy Park 
(2/09/16) and Pippy Park (21/09/16), Pippy Park (2/09/16) and Keels, and between 
Pippy Park (2/09/16) and Ft. Amherst (p=0.003, DF=11). Values represented by the 
same letter indicate there are no significant differences within samples from those 





Figure 3.6: Total phenolic content of the blueberry leaf extracts. 
Significant differences between the leaves from the four samples were 
determined via one-way ANOVA and post hoc Tukeys test (p<0.05). Significant 
differences for the total phenolic content of the leaves are between the Pippy Park 
samples and Keels, the Pippy Park samples and Ft. Amherst, and between Keels 
and Ft. Amherst (p=<0.0001, DF=11). Values represented by the same letter 
indicate there are no significant differences within samples from those 
locations. The data are expressed as the mean ± SE, and are represented in Figure 
3.4. 
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3.1.3 Total flavonoid content 
 
Figure 3.7: Total flavonoid content of blueberry fruit vs leaf extracts. 
Significant differences between the fruits and leaves of the sample were 
determined via two-way ANOVA and post hoc Bonferroni test (p<0.05), 
represented as 0.033(*), 0.002 (**), and <0.0001(***). Significant difference between 
the fruits and the leaves are observed for all four locations, where leaves had a 
higher total flavonoid content than the fruits (p=<0.0001, DF=16). Leaves from 
Pippy Park (2/09/16) and fruits from Keels had the highest total flavonoid 
content. The data are expressed as the mean ± SE.  
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Figure 3.8: Total flavonoid content of the blueberry fruit extracts. 
Significant differences between the fruits from the four samples were 
determined via one-way ANOVA and post hoc Tukeys test (p<0.05). Significant 
differences for the total flavonoid content of the fruits are between the Pippy 
Park samples and Keels, the Pippy Park samples and Ft. Amherst, and between 
Keels and Ft. Amherst (p=<0.001, DF=11). Values represented by the same letter 
indicate there are no significant differences within samples from those 
locations. The data are expressed as the mean ± SE, and are represented in Figure 
3.7.   
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Figure 3.9: Total flavonoid content of the blueberry leaf extracts. 
Significant differences between the leaves from the four samples were 
determined via one-way ANOVA and post hoc Tukeys test (p<0.05). Significant 
differences between the total flavonoid content of the leaves are between Pippy 
Park (2/09/16) and Pippy Park (21/09/16), Pippy Park (2/09/16) and Keels, Pippy 
Park (2/09/16) and Ft. Amherst, Pippy Park (21/09/16) and Keels, and Pippy Park 
(21/09/16) and Ft. Amherst (p=<0.0001, DF=11). Values represented by the same 
letter indicate there are no significant differences within samples from those 
locations. The data are expressed as the mean ± SE, and are represented in Figure 




3.1.4 Total tannin content  
 
Figure 3.10: Total tannin content of blueberry fruit vs leaf extracts. 
Significant differences between the fruits and leaves of the sample were 
determined via two-way ANOVA and post hoc Bonferroni test (p<0.05), 
represented as 0.033(*), 0.002 (**), and <0.0001(***). A significant difference 
between the fruits and leaves are observed for the Pippy Park (2/09/16) sample 
where leaves had a higher total tannin content than the fruits, and for the Keels 
sample where the fruits had a higher total tannin content (p=0.0004, DF=16). Both 
leaves and fruits from Keels had the highest total tannin content. The data are 
expressed as the mean ± SE.   
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Figure 3.11: Total tannin content of the blueberry fruit extracts. 
Significant differences between the fruits from the four samples were 
determined via one-way ANOVA and post hoc Tukeys test (p<0.05). Significant 
differences between the total tannin content of the fruits are between the Pippy 
Park samples and Keels, the Pippy Park samples and Ft. Amherst, and between 
Keels and Ft. Amherst (p=<0.0001, DF=11). Values represented by the same letter 
indicate there are no significant differences within samples from those 
locations. The data are expressed as the mean ± SE, and are represented in Figure 
3.10.    
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Figure 3.12: Total tannin content of the blueberry leaf extracts. 
Significant differences between the leaves from the four samples were 
determined via one-way ANOVA and post hoc Tukeys test (p<0.05). Significant 
differences between the total tannin content of the leaves are between the Pippy 
Park samples and Keels, the Pippy Park samples and Ft. Amherst, and Keels and 
Ft. Amherst (p=<0.0001, DF=11). Values represented by the same letter indicate 
there are no significant differences within samples from those locations. The data 
are expressed as the mean ± SE, and are represented in Figure 3.10.     
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3.1.5 Total anthocyanin content 
 
Figure 3.13: Total anthocyanin content of blueberry fruit vs leaf extracts. 
Significant differences between the fruits and leaves of the sample were 
determined via two-way ANOVA and post hoc Bonferroni test (p<0.05), 
represented as 0.033(*), 0.002 (**), and <0.0001(***). Significant difference between 
the fruits and the leaves are observed for all four samples where fruits had a 
higher total anthocyanin content than the leaves (p=<0.0001, DF=16). Both fruits 
and leaves from Keels contained the highest total anthocyanin content. The data 
are expressed as the mean ± SE.  
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Figure 3.14: Total anthocyanin content of the blueberry fruit extracts. 
Significant differences between the fruits from the four samples were 
determined via one-way ANOVA and post hoc Tukeys test (p<0.05). Significant 
differences for the total anthocyanin content of the fruits are between the Pippy 
Park samples and Keels, and Keels and Ft. Amherst (p=<0.0001, DF=11). Values 
represented by the same letter indicate there are no significant differences within 
samples from those locations. The data are expressed as the mean ± SE, and are 




Figure 3.15: Total anthocyanin content of the blueberry leaf extracts.  
Significant differences between the leaves from the four samples were 
determined via one-way ANOVA and post hoc Tukeys test (p<0.05). Significant 
differences for the total anthocyanin content of the leaves are between Pippy Park 
(2/09/16) and Pippy Park (21/09/16), Pippy Park (21/09/16) and Keels, Pippy Park 
(21/09/16) and Ft. Amherst, and Keels and Ft. Amherst (p=0.002, DF=11). Values 
represented by the same letter indicate there are no significant differences within 
samples from those locations. The data are expressed as the mean ± SE, and are 
represented in Figure 3.13.     
 79 
3.2  High-performancy liquid chromoatography-mass spectrometry   
HPLC-MS is a technique used to separate, detect and potentially identify 
chemicals of particular masses in the presence of other chemicals. HPLC-MS was 
conducted by Michelle Debnath-Canning and Scott Unruh in our research group 
in 2015. The method was adapted from Cho et al., (2004) and literature values 
were obtained from Cho et al., (2004) and Esposito et al., (2014). There were nine 
different major anthocyanins detected using HPLC-MS from blueberry fruit 
extracts from Pippy Park collected in 2014. 
Table 3.1: Anthocyanin compounds identified in blueberry fruit extracts from 
Pippy Park using HPLC-Mass Spectrometry detection at positive ESI. 
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*HPLC-Mass Spectrometry conducted by Michelle Debnath-Canning and Scott 
Unruh in our lab in 2015.  
Through HPLC-MS, nine major anthocyanin compounds were identified 
including: Delphinidin 3-galactoside, Delphinidin 3-glucoside, Cyanidin 3-
galactoside, Delphinidin-3-arabinoside, Cyanidin 3-glucoside, Petunidin-3-
galactoside, Peonidin-3-galactoside, Malvidin-3-galactoside and Peonidin-3-
glucoside. 
3.3 Cell culture experiments  
After determining the phenolic content of the blueberry samples using 
biochemical assays, and analyzing previous HPLC-MS data, I investigated the 
potential neuroprotective effects of these extracts on brain tissue. This was done 
using mixed culture plates (C57BL/6 mouse-pup dissections), and pure rat 
neurons and microglia (ScienCell). Mixed cultures were used to represent the 
conditions normally found in the brain where neurons and many types of glia are 
found. Pure cultures of neurons and microglia were used to determine the direct 
effects of the addition of glutamate, alpha-synuclein, and amyloid-beta on the 
specific cell types. The Pippy Park (21/09/16) sample was chosen based on the 
results of the biochemical assays, as this extract contained high levels of phenolic 
compounds, as well as the quantity and quality of the sample. Cells were 
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quantified by counting the number of DAPI-stained nuclei (% control) after 24-
hours of treatment. All counts were done by two individuals and then averaged. 
After the addition of the blueberry extract to wells treated with 100 μM 
glutamate, 100 ng/ml alpha-synuclein or 7.5 µM amyloid-beta there was an 
increase in the average percent of control for all of the cell types. Statistically 
significant results between the different treatment conditions was determined via 
one-way ANOVA and post hoc Tukeys test (p<0.05), represented as mean ± SE. 
Statisitically significant results in Figure 3.16 were determined via unpaired t-
test, represented as mean ± SE. Each condition within each cell type had at least 
three independent cultures, and n=the number of wells for a given condition.  
3.3.1 Mixed cultures of neurons and glia (dissection plates)  
Figure 3.16 represents the control vs wells treated with the blueberry 
extract. There is no significant difference between the two, and the percent 
control was 98.44 (± 1.56) for the blueberry extract, showing that the addition of 
the blueberry extract did not affect the viability of the cells. Figure 3.17 represents 
the number of DAPI-stained nuclei (% control) for the control, 100 μM glutamate 
treated cells, and 100 μM glutamate plus blueberry extract treated cells. Figure 
3.18 represents the number of DAPI-stained nuclei (% control) for the control, 100 
ng/ml alpha-synuclein treated cells, and 100 ng/ml alpha-synuclein plus 
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blueberry extract treated cells. And Figure 3.19 represents the number of DAPI-
stained nuclei (% control) for the control, 7.5 μM amyloid beta treated cells, and 
7.5 μM amyloid beta plus blueberry extract treated cells. Although not 
significant, there appeared to be a decrease in the number of viable cells after 
wells were treated with 100 μM glutamate, 100 ng/ml alpha-synuclein or 7.5 μM 
amyloid-beta. 
 
Figure 3.16: Dissected mouse neurons and glia treated with pure blueberry 
extract. 
The % of control was determined by quantifying the number of DAPI-
stained nuclei. The n=22 for the control and n=20 for the blueberry extract. There 
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was no significant difference between the control and the blueberry extract 
treated wells (unpaired t-test p=0.96). The data are expressed as the mean ± SE. 
 
Figure 3.17: Dissected mouse neurons and glia treated with 100 μM glutamate. 
The % of control was determined by quantifying the number of DAPI-
stained nuclei. The n=20 for the control, n=18 for glutamate, and n=18 for 
glutamate plus blueberry extract. The one-way ANOVA had a p=0.19 (DF=54). 
Although not statistically significant, the control vs. 100 μM glutamate post hoc 
Tukeys had a p=0.25, 100 μM glutamate vs. 100 μM glutamate plus blueberry 
extract post hoc Tukeys had a p=0.59, and control vs. 100 μM glutamate plus 
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blueberry extract post hoc Tukeys had a p=>0.99. The data are expressed as the 
mean ± SE. 
 
Figure 3.18: Dissected mouse neurons and glia treated with 100 ng/ml alpha-
synuclein. 
The % of control was determined by quantifying the number of DAPI-
stained nuclei. The n=15 for the control, n=16 for alpha-synuclein, and n=16 for 
alpha-synuclein plus blueberry extract. The one-way ANOVA had a p=0.58 
(DF=44). Although not statistically significant, the control vs. 100 ng/ml alpha-
synuclein post hoc Tukeys had a p=0.94, 100 ng/ml alpha-synuclein vs. 100 ng/ml 
alpha-synuclein plus blueberry extract post hoc Tukeys had a p=0.89, and control 
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vs. 100 ng/ml alpha-synuclein plus blueberry extract post hoc Tukeys had a 
p=>0.99. The data are expressed as the mean ± SE. 
 
Figure 3.19: Dissected mouse neurons and glia treated with 7.5 μM amyloid-
beta. 
The % of control was determined by quantifying the number of DAPI-
stained nuclei, and n=12 for all conditions. The one-way ANOVA had a p=0.16 
(DF=33). Although not statistically significant, the control vs. 7.5 μM amyloid-
beta post hoc Tukeys had a p=0.20, 7.5 μM amyloid-beta vs. 7.5 μM amyloid-beta 
plus blueberry extract post hoc Tukeys had a p=0.53, and control vs. 7.5 μM 
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amyloid-beta plus blueberry extract post hoc Tukeys had a p=>0.99. The data are 
expressed as the mean ± SE. 
3.3.2 Rat neurons  
Figure 3.20 represents the number of DAPI-stained nuclei (% control) for 
the control, 100 μM glutamate treated neurons, and 100 μM glutamate plus 
blueberry extract treated neurons. Figure 3.21 represents the number of DAPI-
stained nuclei (% control) for the control, 100 ng/ml alpha-synuclein treated 
neurons, and 100 ng/ml alpha-synuclein plus blueberry extract treated neurons. 
And Figure 3.22 represents the number of DAPI-stained nuclei (% control) for the 
control, 7.5 μM amyloid beta treated neurons, and 7.5 μM amyloid beta plus 
blueberry extract treated neurons.  A significant difference is observed between 
the control and 100 μM glutamate and 7.5 μM amyloid beta treated wells, 
although not statistically significant the addition of alpha-synuclein also resulted 
in a reduction in viable cells. This shows that the addition of excess glutamate 
and amyloid-beta resulted in a decrease in the number of cells present after 24-
hours of treatment. There was an increase in the number of viable cells when 
blueberry extract was added to culture wells treated with 100 μM glutamate or 
7.5 μM amyloid-beta, resulting in numbers closer to the number of cells in the 
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control wells. Pure blueberry extract alone was tested in the neurons (n=6) and 
was not statistically significant from the control.  
 
Figure 3.20: Rat neurons treated with 100 μM glutamate. 
The % of control was determined by quantifying the number of DAPI-
stained nuclei. The n=7 for the control, n=9 for glutamate, and n=9 for glutamate 
plus blueberry extract. The one-way ANOVA had a p=0.03 (DF=22). Statistical 
significance (* p<0.05) was determined between control and 100 μM glutamate 
treated wells (post hoc Tukeys p=0.03). Although not statistically significant, 100 
μM glutamate vs. 100 μM glutamate plus blueberry extract post hoc Tukeys had a 
 88 
p=0.33, and control vs. 100 μM glutamate plus blueberry extract post hoc Tukeys 
had a p=0.67. The data are expressed as the mean ± SE. 
 
Figure 3.21: Rat neurons treated with 100 ng/ml alpha-synuclein. 
The % of control was determined by quantifying the number of DAPI-
stained nuclei. The n=10 for the control, n=8 for alpha-synuclein, and n=10 for 
alpha-synuclein plus blueberry extract. The one-way ANOVA had a p=0.31 
(DF=25). Although not statistically significant, the control vs. 100 ng/ml alpha-
synuclein post hoc Tukeys had a p=0.58, 100 ng/ml alpha-synuclein vs. 100 ng/ml 
alpha-synuclein plus blueberry extract post hoc Tukeys had a p=>0.99, and control 
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vs. 100 ng/ml alpha-synuclein plus blueberry extract post hoc Tukeys had a 
p=0.58. The data are expressed as the mean ± SE. 
 
Figure 3.22: Rat neurons treated with 7.5 μM amyloid-beta. 
The % of control was determined by quantifying the number of DAPI-
stained nuclei. The n=10 for the control, n=8 for amyloid-beta, and n=8 for 
amyloid-beta plus blueberry extract. The one-way ANOVA had a p=0.008 
(DF=23). Statistical significance (* p<0.05) was determined between control and 
7.5μM amyloid-beta treated wells (post hoc Tukeys p=0.006). Although not 
statistically significant, 7.5 μM amyloid-beta vs. 7.5 μM amyloid-beta plus 
blueberry extract post hoc Tukeys had a p=0.14, and control vs. 7.5 μM amyloid-
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beta plus blueberry extract post hoc Tukeys had a p=0.53. The data are expressed 
as the mean ± SE. 
3.3.3 Rat microglia  
Figure 3.23 represents the number of DAPI-stained nuclei (% control) for the 
control, 100 μM glutamate treated microglia, and 100 μM glutamate plus 
blueberry extract treated microglia. Figure 3.24 represents the number of DAPI-
stained nuclei (% control) for the control, 100 ng/ml alpha-synuclein treated 
microglia, and 100 ng/ml alpha-synuclein plus blueberry extract treated 
microglia. Although not statistically significant, there appeared to be an increase 
in the number of viable cells when blueberry extract was added to culture wells 
treated with 100 ng/ml alpha-synuclein, resulting in numbers close to the number 
of cells under control treatment. A significant difference is observed between the 
control and 100 ng/ml alpha-synuclein treated wells, showing that the addition of 
alpha-synuclein to these cultures resulted in a significant decrease in the number 
of cells present.  
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Figure 3.23: Rat microglia treated with 100 μM glutamate. 
The % of control was determined by quantifying the number of DAPI-
stained nuclei, and n=10 for all of the conditions. The one-way ANOVA had a 
p=0.19 (DF=27). Although not statistically significant, the control vs. 100 μM 
glutamate post hoc Tukeys had a p=0.77, 100 μM glutamate vs. 100 μM glutamate 
plus blueberry extract post hoc Tukeys had a p=0.98, and control vs. 100 μM 
glutamate plus blueberry extract post hoc Tukeys had a p=0.86. The data are 
expressed as the mean ± SE. 
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Figure 3.24: Rat microglia treated with 100 ng/ml alpha-synuclein. 
The % of control was determined by quantifying the number of DAPI-
stained nuclei. The n=14 for the control, n=12 for alpha-synuclein, and n=14 for 
alpha-synuclein plus blueberry extract. The one-way ANOVA had a p=0.007 
(DF=20). Statistical significance (* p<0.05) was determined between control and 
100 ng/ml alpha-synuclein treated wells (post hoc Tukeys p=0.006). Although, not 
statistically significant, 100 ng/ml alpha-synuclein vs. 100 ng/ml alpha-synuclein 
plus blueberry extract wells post hoc Tukeys had a p=0.29, and the control vs. 100 
ng/ml alpha-synuclein plus blueberry extract post hoc Tukeys had a p=0.30. The 
data are expressed as the mean ± SE. 
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3.3.4 Confocal imaging of caspase-3 in mixed cultures 
Caspase-3 is a marker of apoptosis and was used to determine the extent 
of programmed cell death in mixed cultures of neurons and glia treated with 
alpha-synuclein. Images captured by Dr. Noriko Daneshtalab show mixed 
culture morphology as well as cellular compartmentalization of activated 
caspase-3 in control wells (A), alpha-synuclein treated wells (B), and wells 
treated with alpha-synuclein plus the Pippy Park (21/09/16) blueberry extract (C). 
Each image includes the DAPI image (i) in blue, activated caspase-3 (ii) (Alexa 
488 goat anti-rabbit) in green, and the merged image (iii). Images were taken at 8-

























Figure 3.25: Confocal images of DAPI and activated caspase-3 in an 100 ng/ml 
alpha-synuclein treated dissection plate. (A) Control wells, (B) alpha-synuclein 
treated wells, and (C) wells treated with alpha-synuclein plus the blueberry 
extract. DAPI image (i) in blue, activated caspase-3 (ii) in green, and the merged 
image (iii). Scale bar, 50 μM. 
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When observed under the confocal microscope, as well as in the captured 
images in Figure 3.25, cells in the control wells (A) appear healthier, circular and 
more spread out, whereas cells in the alpha-synuclein treated wells (B) look 
damaged, with an uneven shape and border, and are clumped together. Cells in 
the control wells (A), and alpha-synuclein plus Pippy Park (21/09/16) blueberry 
extract wells (C) appear more elongated compared to those wells that were 
treated with just alpha-synuclein. There was a difference with regard to the 
cellular localization of activated caspase-3 among the different treatment 
conditions. The different subcellular compartmentalization of caspase-3 may play 
a role in apoptosis activation as translocation of caspase-3 is critical for the 
development of the apoptotic pathway (Kamada et al., 2005).  In the control wells 
(A) and the alpha-synuclein plus blueberry extract wells (C), activated caspase-3 
appeared to be mainly in the cytoplasm. However, with the alpha-synuclein 
treated wells (B) activated caspase-3 appeared to be localized just in the nucleus.  
3.3.5 Immunofluorescence imaging of neurons 
The images in Figure 3.26 were captured with a fluoresce microscope at a 
magnification of 40X using PCO Camware software (see Figure 2.1). Images 
captured cell morphology and cellular differentiation of pure neurons (ScienCell) 
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in control (A), alpha-synuclein treated wells (B), and wells treated with alpha-
synuclein plus the Pippy Park (21/09/16) blueberry extract (C). 
 
 
Figure 3.26: Immunoflorescence microscope imaging with DAPI staining in 
pure rat neurons treated with alpha-synuclein. 
Neurons in the control wells (A) are very elongated and look healthy 
compared to cells in the alpha-synuclein treated wells (B). The cells in the alpha-
synuclein treated wells are compact with little to no elongation. These cells were 
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observed to be very clumped together, where sections of the well would have no 
cells at all, but then other areas had cells layered on top of each other. The 
neurons in the wells treated with alpha-synuclein plus the Pippy Park (21/09/16) 
blueberry extract (C) contain both clumped/round and elongated neurons. 
Therefore, the addition of the blueberry extract appeared to promote the growth, 
and elongation of healthy neurons when in the presence of alpha-synuclein.  
3.4 Pilot diet study  
In order to determine the palatability of a 2% blueberry-enriched diet, a 
pilot feeding study was conducted. Blueberries collected from Pippy Park 
(21/09/16) were administered to C57BL/6 mice over a 5-week period. There were 
18 mice involved in this study, however one mouse from the control group died 
during this study from a seizure on day 10. The Pippy Park (21/09/16) sample 
was chosen based on the results of the biochemical assays, because we had the 
highest quantity of it, and because it was previously used for the cell culture 
studies. Through two-way ANOVA and post hoc Bonferroni test (p<0.05), results 
show that there was no significant weight change from the initial to the final date 
of the pilot study, showing that administration of the mash is palatable over time 
(Figure 3.27). Currently, the brains of these mice remain in a -80°C freezer 
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awaiting HPLC-MS analysis to detect and identify specific compounds from the 
blueberries present in the brain tissue.  
Mice were tested on a rotarod apparatus in order to monitor motor function 
over the course of this study. For all speeds (5 rpm, 10 rpm, 15 rpm) of the fixed-
speed rotarod testing, a slight incline was observed where the experimental 
group was able to stay on the rotarod for a longer period of time by the end of 
the study. Results showed no statically significant results between the control 
and experimental groups at any of the speeds, via two-way ANOVA and post hoc 
Bonferroni test (p<0.05). For NOR testing, the experimental group had a higher 
DI in the 1-hour trails, showing they were able to make a concrete memory of the 
familiar object, because they explored the novel object more. The 24-hour trials 
saw opposite results, and animals in both groups had a very low DI. There were 
no significant differences between the control and experimental groups for NOR 
testing at 1-hour or at 24-hours, and no significant differences between the 1-hour 




Figure 3.27: Daily mean weight measurements for the control and experimental 
groups. 
All animals were able to maintain their weight, or gain weight when 
voluntarily consuming the blueberry mash, concluding that the berry-enriched 
diet is palatable over time. No statistically significant differences (two-way 
ANOVA and post hoc Bonferroni test, p<0.05) were observed between the groups, 
or between the individual animals starting and final weight (p=0.997, f-
value=0.03, DF=510). The data are expressed as the mean ± SE. 
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3.4.1 Rotarod  
 
Figure 3.28: Rotarod test day means for the control and experimental groups at 
5 rpm. 
At 5 rpm there are no significant differences (two-way ANOVA and post 
hoc Bonferroni test, p<0.05) between the test day means for the control and 
experimental groups (p=0.262, f-value=1.28, DF=120). The experimental group 
initially had lower scores but were able to stay on the rotarod longer at 5 rpm by 
the end of the study. Animals in both groups were able to stay on the longest at 




Figure 3.29: Rotarod test day means for the control and experimental groups at 
10 rpm. 
At 10 rpm there are no significant differences (two-way ANOVA and post 
hoc Bonferroni test, p<0.05) between the test day means for the control and 
experimental groups (p=0.883, f-value=0.43, DF=120). The experimental group 
continuously performed better on the rotarod (with the exception of August 17th), 
whereas the control group did not improve very much throughout the study. The 




Figure 3.30: Rotarod test day means for the control and experimental groups at 
15 rpm. 
At 15 rpm there are no significant differences (two-way ANOVA and post 
hoc Bonferroni test, p<0.05) between the test day means for the control and 
experimental groups (p=0.869, f-value=0.45, DF=120). Both groups were able to 
gradually improve throughout the study. At the beginning of the study the 
control group was able to stay on the rotarod longer at 15 rpm, however by the 
end of the study the experimental group performed better. The data are 
expressed as the mean ± SE. 
3.4.2 Novel object recognition  
The discrimination index is above zero for both the 1-hour trials and 24-
hour trials, indicating that the animals in both groups retained a memory of the 
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familiar object and preferred to explore the novel. The experimental group spent 
more time exploring the novel object compared to the control in the 1-hour trials, 
and the opposite was seen in the 24-hour trials. Reliability stats using Cronbach’s 
Alpha were also determined (1-hour familiar: 0.93, 1-hour novel: 0.92 and 24-
hour familiar: 0.89, 24-hour novel: 0.9). 
 
Figure 3.31: Novel object recognition for the 1-hour and 24-hour trials. 
There are no significant differences (two-way ANOVA and post hoc 
Bonferroni test, p<0.05) between the control and experimental groups for the 1-
hour or 24-hour trials (p=0.629, f-value=0.24, DF=30). The opposite is seen for the 
24-hour trials, as the DI for both groups was lower, which is expected as time 
increases, however, the DI for the experimental group was low compared to 
testing the previous day. This could be due to a number of factors which will be 
examined in Chapter 4. The data are expressed as the mean ± SE. 
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Chapter 4: Discussion  
4.1 Biochemical analysis  
Blueberry (Vaccinium angustifolium spp.) fruits and leaves collected from 
Pippy Park, Keels and Ft. Amherst in Newfoundland and Labrador were 
analyzed using biochemical assays. It was determined that both the fruits and 
leaves contained high levels of phenolic compounds including flavonoids, 
anthocyanins, and tannins. These samples showed high antioxidant activity 
measured as the total radical scavenging capacity. For total phenolic content, 
total antioxidant activity, and total flavonoid content the leaves were 
significantly higher than the fruits. This is consistent with previous findings in 
our research group (Vyas et al., 2013), where the leaves contained higher levels of 
phenolic compounds for both blueberries and lingonberries. Total tannin content 
saw mixed results where both Pippy Park samples had higher levels in the leaves 
and Keels and Ft. Amherst had higher levels in the fruits. For the total 
anthocyanin content, the fruits were significantly higher than the leaves for all 
the locations. Anthocyanins are responsible for the red and blue pigments found 
in the fruits of berries (Hossain et al., 2016). Berries store the majority of their 
anthocyanins in the skin, which help protect the fruit from harmful interactions 
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with the sun and other environmental factors (Hossain et al., 2016), so it makes 
sense that higher levels of anthocyanins are in the fruits.  
Total antioxidant activity was the highest in the leaves collected from 
Pippy Park (2/09/16), and in the fruits collected from Keels (17/09/17). Total 
phenolic content was the highest in the leaves collected from Ft. Amherst 
(25/08/17), and the fruits collected from Pippy Park (21/09/16). Total flavonoid 
content was highest in the leaves collected from Pippy Park (2/09/16) and fruits 
from Keels (17/09/17). Total tannin content and total anthocyanin content was 
highest in the leaves and fruits collected from Keels (17/09/17). Even though 
samples were collected from the same geographical area there are significant 
differences observed among the samples depending on the biochemical assay. It 
is particularly interesting to see a significant difference between the two Pippy 
Park samples even though they were collected from the same location just a few 
weeks apart (Figures 3.3, 3.5, 3.9, and 3.15). Similar results were observed in a 
study conducted by Connor et al. (2002) which found differences between total 
antioxidant capacity, total phenolic content, and total anthocyanin content 
between samples collected from the same location. This gives us insight into the 
variety of phenolic compounds that can exist within a particular area based on 
environmental factors and different genotypes (Connor et al, 2002). Collection 
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times could have played a role in the difference, based on the ripeness and size of 
the berry, a decrease in temperature or changes in weather patterns.  
The total tannin content for both Pippy Park samples is particularly low, 
as seen in Figure 3.10. Tannin content is highly dependent on the stage of 
development and ripening of the plant (Hanlin & Downey, 2009). The tannin 
content of plants tends to decrease after the plant is mature and the fruit is ripe 
(Hanlin & Downey, 2009). Wild blueberries ripen in early August into 
September, and the Pippy Park samples were collected in September. This could 
have influenced these results, but these samples were collected around the same 
time as the Keels and Fort Amherst samples which had a significantly higher 
total tannin content for both fruits and leaves. Therefore, the environmental 
factors associated with their location may have played a bigger role in the total 
tannin content. Plants growing in areas more exposed to sunlight have much 
higher levels of tannins compared to those that are in more shaded areas 
(Nichols-Orians, 1991). The Pippy Park samples were collected in a flat area on 
top of a peak. There were several tree and bush species growing in this area as 
well, which provided partial shading to most of the blueberry plants.  
After determining the levels of polyphenols present in the samples, we 
examined the specific anthocyanin compounds detected in previous samples in 
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our lab. HPLC-MS was conducted on a Pippy Park sample collected in 2014, 
where a total of nine major anthocyanin compounds were found in the fruits of 
this sample (Table 3.1). Through HPLC-MS Michelle Debnath-Canning and Scott 
Unruh were able to identify Delphinidin 3-galactoside, Delphinidin 3-glucoside, 
Cyanidin 3-galactoside, Delphinidin-3-arabinoside, Cyanidin 3-glucoside, 
Petunidin-3-galactoside, Peonidin-3-galactoside, Malvidin-3-galactoside and 
Peonidin-3-glucoside. Previous HPLC-MS analysis was conducted in our lab on 
the leaves from the 2016 Pippy Park sample, resulting in the identification of only 
six major compounds. Although the leaves have higher activity in biochemical 
assays, they contain fewer distinct phenolic compounds. The HPLC-MS data for 
the fruits gives us insight into potentially active compounds responsible for 
neuroprotection and free radical scavenging ability of polyphenols as well as 
determining the difference between 2014 and 2016 samples. Further HPLC-MS 
data would be beneficial to our lab, not only to identify and quantify the levels of 
anthocyanins and other phenolic compounds but to determine the different 
compounds present based on geographical location, and determine if these 
specific compounds can be detected in brain tissue and other organs after the 
consumption of the extract. Andres-Lacueva et al. (2013) was able to detect 8 
major anthocyanins, including six compounds (Delphinidin 3-galactoside, 
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Cyanidin 3-galactoside, Delphinidin-3-arabinoside, Cyanidin 3-glucoside, 
Peonidin-3-galactoside, and Malvidin-3-galactoside) found in Table 3.1, in the 
cerebellum, cortex, hippocampus and striatum of aged rats fed a 2% blueberry-
enriched diet for 8 to 10 weeks.  
4.2 Cell culture studies  
After analyzing the biochemical properties of the blueberry samples, we 
determined the neuroprotective role of these blueberries in vitro. As previously 
mentioned the Pippy Park (21/09/16) sample was used for the cell culture 
experiments because this sample contained high levels of phenolic compounds 
and was of the highest quality and quantity, compared to the other three 
samples. The fruit extracts were chosen over the leaf extracts because the fruits 
are more palatable. The fruits are generally consumed more often than the leaves, 
and using the leaves, which are in a powder after extraction, would require the 
addition of solvent into the wells. We primarily wanted to focus on using a 
blueberry extract that was pure blueberries and contained no solvent at all, so it 
would mimic what an individual or an animal in an in vivo study would 
consume. Previous studies conducted by our research group have only tested 
blueberries diluted with solvent in cell culture. We were able to sterilize and add 
just pure blueberries after mashing up whole berries without the addition of any 
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potentially toxic compounds (i.e. acetone/formic acid). Mixed culture plates, 
including neurons and glia from dissected 1 to 3 day old C57BL/6 mouse brains 
were tested along with pure cultures of neurons and microglia isolated from 
postnatal day 2 CD® IGS rat brains. For each well, 5 images were taken and the 
number of DAPI-stained nuclei (% control) was quantified by two individuals.  
First, the pure blueberry extract was tested by itself to see if it had any 
effect on cell viability. It was determined that the addition of the blueberry 
extract resulted in no significant differences in cell numbers (Figure 3.16). The 
neuroprotective role of the blueberry extract was then tested against glutamate-
mediated excitotoxicity. Glutamate-mediated excitotoxicity is primarily caused 
by high levels of glutamate from the inadequate uptake of glutamate through 
transporters in glial cells. This results in extensive cell death and damage by 
overstimulating glutamate receptors leading to oxidative stress (Figueira et al., 
2017) and neuroinflammation (Morales et al., 2016) in the CNS. Previous cell 
culture studies conducted in our lab have concluded that the addition of 
blueberry extracts to mixed cultures of rat brain cells showed neuroprotection 
against glutamate-mediated excitotoxicity (Vyas et al., 2013). This study along 
with work conducted by Michelle Debnath-Canning set the parameters for the 
final 100 μM glutamate concentration that was used. For the rat neurons (Figure 
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3.20), there was a significant decrease in the number of cells present compared to 
the control, showing that the addition of excess glutamate to these wells resulted 
in cell damage and death. Wells treated with glutamate and the blueberry extract 
saw an increase in the number of DAPI-stained nuclei compared to the glutamate 
treated wells. For the rat microglia (Figure 3.23), a similar trend was observed, 
where the addition of excess glutamate resulted in a decrease in the number of 
viable cells compared to the control, however this result was not significant. 
There were no significant differences observed between the treatment groups for 
the dissection plates consisting of neurons and glia (Figure 3.17), however, there 
appeared to be a potential decrease in the number of cells when excess glutamate 
was added to the wells. For the dissection plates there appeared to be an increase 
in the number of cells when the blueberry extract was added to culture wells 
treated with 100 μM glutamate, although it was not significant, the trend 
suggests that the addition of the blueberry extract was able to increase cell 
numbers closer the numbers observed in the control wells. 
As stated above, there were significant differences observed when excess 
glutamate was added to pure rat neurons but not the microglia. Neurons were 
likely more affected by glutamate because they use glutamate extensively as an 
excitatory neurotransmitter to transmit signals from one neuron to the other. 
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Therefore, they may have been more susceptible or sensitive to glutamate 
increase compared to the microglia which have fewer glutamate receptors 
(Matute et al., 2006). Microglia are the least susceptible to excitotoxcicity 
compared to other cells in the CNS, and that glutamate receptors are generally 
only expressed when microglia are in their activated form. It is also suggested 
that microglia are able to uptake glutamate and metabolize it to glutamine, 
resulting in a clearance of extracellular glutamate and reduction in its excitotoxic 
effects (Howe & Barres, 2012). The ability of microglia to eliminate excess 
glutamate within the surrounding area would have led to a decrease in the 
amount of cell death and damage caused by overstimulation.  
We also wanted to look at the neuroprotective role the blueberry extract 
may have on cells treated with alpha-synuclein. The final concentration for 
alpha-synuclein (100 ng/ml) was determined by the research team Dr. Weber was 
previously a part of at the University of Marburg, Germany (data not published). 
The abnormal accumulation of alpha-synuclein protein caused by chronic 
neuroinflammation and oxidative stress (Strathearn et al., 2014), is one of the 
pathological markers associated with PD. These insoluble aggregates damage the 
DA neurons in the SNpc contributing to the painful motor dysfunctions 
associated with PD (Strathearn et al., 2014). Aggregates of alpha-synuclein can 
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activate surrounding microglia, contributing to inflammation by promoting the 
release of inflammatory cytokines (Block et al., 2007). In Figure 3.24, there is a 
significant difference between the control treatment and the alpha-synuclein 
treated wells for the microglia, where the addition of alpha-synuclein resulted in 
a significant decrease in the number of viable cells, showing that this protein in 
vitro was capable of causing extensive cell death and damage, similarly to the 
pathology seen in PD. For the microglia wells treated with alpha-synuclein and 
the blueberry extract, there appeared to be an increase in the number of DAPI-
stained nuclei compared to the alpha-synuclein treated wells. There was no 
significant difference between the control and wells treated with alpha-synuclein 
for the neurons, even though there appeared to be a decrease in the number of 
cells present after alpha-synuclein was added for 24-hours.  Similarly, to the 
glutamate treated dissection plates, the dissection plates treated with alpha-
synuclein saw no significant difference between the treatment conditions. 
However, the trends suggest that there was a decrease in the number of cells in 
the conditions where alpha-synuclein was added, and the addition of the 
blueberry extract to these wells resulted in an increase in the number of cells 
present.  
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There were significant differences observed when alpha-synuclein was 
added to pure rat microglia but not the neurons. Microglia were much more 
sensitive to the addition of alpha-synuclein compared to the neurons, and 
responded better to the addition of the blueberry extract. Microglia are 
responsible for the immune response in the CNS, and can uptake excess or 
abnormally folded alpha-synuclein to reduce cell death and damage (Zhang et al., 
2005). The increased presence of this protein promotes the activation of microglia 
which leads to an inflammatory response and the release of cytokines. This 
activates other surrounding microglia, resulting in oxidative stress and cellular 
damage (Zhang et al., 2005). Therefore, one of the potential neuroprotective 
mechanisms associated with blueberries is preventing the activation of 
microglia. Neurons were not as directly affected as the microglia following the 
addition of alpha-synuclein, as this protein might not be as readily taken up in 
the neurons during this 24-hour treatment period.  
Finally, we looked at the neuroprotective role of the blueberry extract 
when cells are treated with amyloid-beta. The final concentration of amyloid-beta 
(7.5 μM) was determined by work conducted by Nafar and Mearow (2014). 
Amyloid-beta in high concentrations and the accumulation of insoluble amyloid-
beta-peptide plaques is one of the underlying mechanisms associated with AD. 
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Amyloid-beta buildup in between nerve cells in the hippocampus causes 
extensive damage and prevents neurons from functioning properly resulting in 
cognitive issues, such as the formation of new memories (Balk et al., 2006). 
Dysfunction of the mitochondrial electron transport chain and long-term 
oxidative stress is associated with the aggregation of amyloid-beta (Balk et al., 
2006). For the rat neurons, there was a significant difference observed between 
the control and amyloid-beta treated wells. The addition of blueberry extract to 
wells treated with amyloid-beta resulted in an increase in the number of neurons 
present. The addition of amyloid-beta in the dissection plates was not statistically 
significant from the control, however there appeared to be a decrease in the 
number of viable cells when amyloid-beta was added. There also appeared to be 
an increase in the number of cells present when the blueberry extract was added 
to wells treated with amyloid-beta in the dissection plates.  
For the neurons, the addition of amyloid-beta was significant but the 
addition of alpha-synuclein was not. The neurons were more sensitive to 
amyloid-beta aggregation and responded more positively to the addition of the 
blueberry extract. Alpha-synuclein is a protein that is abundant in the brain, 
however its function is poorly understood. The pathological issues associated 
with alpha-synuclein only arise when the protein becomes misfolded and begins 
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to aggregate (Masliah et al., 2001). Amyloid-beta is also present in the brain, just 
in much lower levels, however when amyloid-beta is in high concentrations it is 
very toxic whether it is aggregated or not. Therefore, for this reason the addition 
of excess amyloid-beta to the culture wells for the 24-hour period could have had 
a greater effect and resulted in extensive cell damage to neurons compared to 
alpha-synuclein. Masliah et al. (2001) observed that transgenic mice with 
neuronal expression of amyloid-beta developed motor deficits before transgenic 
alpha-synuclein mice. Furthermore, the authors show that amyloid-beta plaques 
are able to promote the aggregation of alpha-synuclein in transgenic mouse 
models showing the connected relationship between AD and PD (Chaves et al., 
2010).  
There were significant differences observed between the treatment groups 
for the pure rat neurons and microglia, however not for the dissection plates, 
containing both neurons and glia. There was a greater extent of cell death 
observed in the pure rat neurons and microglia compared to dissection plates. 
For example, there was a decrease in the number of cells by 48.5% on average 
after the addition of glutamate in pure rat neurons and microglia. However, for 
the dissection plates there was only a decrease in the number of cells by 37.7% 
after the addition of glutamate. For the pure rat neurons and microglia, the 
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addition of alpha-synuclein resulted in a decrease in the number of cells by 45.2% 
on average, where the reduction was only 28.9% for the dissection plates. The 
presence of different types of glia in the dissection plates may have influenced 
this result. Glia, particularly astrocytes and oligodendrocytes, which are not 
present in the isolated neurons and microglia cultures, are able to take up excess 
glutamate or alpha-synuclein (Brück et al., 2016; Matute et al., 2006), which would 
reduce their overall presence in the well, resulting in a decrease in cell death and 
damage. Alpha-synuclein aggregates have been detected in the cytoplasm of 
astroglial and oligodendroglial cells in vitro (Wakabayashi et al., 2000; Brück et al., 
2016). These types of glia present in the brain were able to provide additional 
protection for surrounding cells by reducing the levels of glutamate and alpha-
synuclein. These plates are more representative of the actual human brain 
including all the cell types. However, it is still beneficial to study the pure 
cultures as one is able to observe the direct effects that these pathological markers 
have on specific cell types in the brain.  
The concentration of blueberry extract used was determined by our 
research group, and by looking at similar studies conducted in the field. In the 
future, it would be beneficial to further investigate different concentrations of 
blueberry extract to determine the specific effects they would have on dose 
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response curves and morphology. It would also be interesting to conduct 
incubations with different time periods instead of only 24-hours to determine 
different stages/levels of of neuroinflammation. Insoluble alpha-synuclein and 
amyloid-beta aggregates may require longer exposure to neurons which could 
play a role in why we observed a limited response.  
The caspase-3 protein plays a key role in triggering apoptosis, and we 
wanted to investigate whether the addition of the blueberry extract had any 
effect on the presence of caspase-3 in mixed culture plates. Although in the 
confocal images captured I was not able to clearly quantify the levels of activated 
caspase-3 between the three treatment conditions, it is evident in the confocal 
images in shown in Figure 3.25 that there are differences among the cellular 
compartmentalization of activated caspase-3. The different subcellular 
compartments may play a role in apoptosis activation as translocation of caspase-
3 is critical for the development and regulation of the apoptotic pathway 
(Kamada et al., 2005). For the control wells (Figure 3.25A) and wells treated with 
alpha-synuclein plus blueberry extract (Figure 3.25C), caspase-3 is primarily 
localized in the cytoplasm, which is particularly evident when looking at the 
merged images (ii). However, with the alpha-synuclein treated wells (Figure 
3.25B) activated caspase-3 appears to be localized just in the nucleus. Similar 
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results were observed by Kamada et al. (2005) where activated caspase-3 was first 
observed in the cytoplasm and then in the nucleus in apoptotic cells. It is 
suggested that some cytoplasmic substrates, such as caspase-3, translocate into 
the nucleus from the cytoplasm following apoptosis induction, resulting in a 
nuclear accumulation of active caspase-3 during apoptosis (Kamada et al., 2005). 
This could suggest that cells treated with alpha-synuclein are more likely to 
undergo apoptosis. Feng et al. (2005) initially saw the activation of caspase-3 on 
the inner surface of the cellular membrane, where it was then transported to the 
cytoplasm and then translocated into the nucleus. The authors suggest that the 
different subcellular localizations are directly related to the steps in the apoptotic 
pathway, which results in changes in cell morphology throughout the process. 
This could suggest that the cells treated with alpha-synuclein go through the 
apoptotic pathway faster than cells in the control wells, and the addition of 
alpha-synuclein could result in immediate induction of apoptosis. In wells 
treated with alpha-synuclein plus blueberry extract, caspase-3 is present in the 
both the nucleus and cytoplasm. Therefore, the addition of the blueberry extract 
may protect the cells by limiting the activation of apoptosis, or even slow the 
progression of the apoptotic pathway. The cells may be given more time to 
properly shut down or fix some of the damage caused by the addition of alpha-
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synuclein. However, more research still needs to be conducted to determine the 
exact location of capase-3 within cells treated with our blueberry extract. This 
will require further caspase-3 labeling, as well at the determination of cell types 
in our dissection plates using specific antibody labeling or using pure cultures, as 
the translocation and compartmentalization may be dependent on the cell type 
and how it specifically regulates apoptosis.  
Using confocal microscopy, there were differences in cell morphology 
observed between the conditions. Cells in the control wells looked healthier, 
stained better, and were more dispersed. Cells in the alpha-synuclein treated 
wells however, were clumped together. Cells treated with alpha-synuclein plus 
the blueberry extract were more dispersed, however did contain areas of 
clumped cells. This conclusion may not be entirely evident in all of the images 
that were captured but certainly was evident under the confocal microscope. This 
may likely be due to the fact that the alpha-synuclein treated cells were clumped 
and damaged resulting in faint Alexa 488 labeling.  
The images in Figure 3.26 capture differences in cell morphology and 
cellular differentiation of pure neurons in control (A), alpha-synuclein treated 
wells (B), and wells treated with alpha-synuclein plus the Pippy Park (21/09/16) 
blueberry extract (C). Neurons in the control wells are very elongated and show 
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different levels of differentiation. Neurons in the alpha-synuclein treated wells 
however show no neuronal elongation and are very clumped together. In the 
wells treated with alpha-synuclein plus the blueberry extract there was some 
elongation seen in these wells, however, not nearly as much as in the control 
wells. There was clumping seen in these wells, but not to the extent it was 
observed in the wells without the blueberry extract. The presence of the extract 
was able to not only show protection in reducing the amount of cell death (Figure 
3.20), but the extract was able to promote morphology associated with healthy 
neurons even in the presence of alpha-synuclein. Even though both 
morphologies were observed in these wells we can conclude that the addition of 
the blueberry extract was able to promote elongation and prevent the cells from 
clumping together. Axon growth is not a default action for neurons and must be 
properly and specifically signaled (Goldberg, 2004). Therefore, the addition of 
alpha-synuclein may interrupt these specific signaling pathways, and the 
blueberry extract may prevent alpha-synuclein from interfering. Sharada et al. 
(2015) found a similar result where hippocampal neurons were treated with 
alpha-synuclein, which resulted in defective axon elongation and blunted growth 
cone turning. Similarly, Takenouchi et al. (2000) showed that rat neurons 
transfected with human alpha-synuclein resulted in a decrease in neurite 
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extension. However, in this study the addition of antioxidants including catalase, 
superoxide dismutase and vitamin E, were not able to significantly affect neurite 
extension.  
4.3 Pilot diet study 
We wanted to determine the palatability of a 2% blueberry enriched diet in 
C57BL/6 mice, which took place over 5 weeks. As mentioned previously, most 
studies, including those conducted in our lab use oral gavage as the route of 
administration. Oral gavage has been shown to lead to differences in 
bioavailability (Atcha et al., 2010), be very stressful for the animals (Balcombe et 
al., 2004), and potentially cause extensive internal damage (Vandenberg et al., 
2014). To avoid these concerns, a plain mash (control) or a 2% blueberry-mash 
(experimental) was provided to the animals’ ad lib overnight. Every morning the 
dishes were empty for both the control and experimental groups, showing that 
all 5 g of the mash was consumed by each animal without having to force them to 
consume it. There was no significant weight gain or loss for any of the animals or 
any adverse behavioral issues (aggression, anxiety, fighting, lack of grooming), 
showing that this method of feeding is palatable over time. Moving forward it 
might be worth looking at the amount of food (pellets during the day) and water 
consumed daily, to see if the blueberry extract had any effect on their intake. In 
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the future, it might be interesting to look at the different levels of stress-related 
hormones in the animals fed via oral gavage and those fed the blueberry-mash. 
Also, determining the palatability of a blueberry leaf-enriched diet using the 
mash would be very important to investigate. The leaves are much more bitter 
than the fruits, and it would be interesting to see if the animals would be 
interested in voluntarily consuming the mash with leaf extract added, and 
whether this may influence weight.  
Fixed-speed rotarod testing at 5 rpm, 10 rpm, and 15 rpm was conducted 
throughout the study for a total of 8 sessions. There were no significant 
differences observed between the experimental and the control group at any of 
the speeds. However, there was a slight incline observed for all three speeds, 
suggesting that by the end of the study the experimental group was potentially 
able to stay on the rod slightly longer. This may suggest that the animals in the 
experimental group could have potentially had better motor coordination and 
balance, and were able to gradually improve over the course of the study. This 
observation would likely be more evident if the sample size was larger and the 
study had continued for longer than 5-weeks. For the 5 rpm trials there is not a 
lot of difference between the two groups, the animals in both groups were able to 
stay on the longest at 5 rpm, as it is the slowest and least difficult, however the 
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experimental group performed better than the control for the last three test days 
of the study. For the 10 rpm trials there is a slight difference observed between 
the two groups, where the controls were only able to stay on the rod for an 
average of 75 to 90 seconds by the end of the study, whereas the majority of the 
animals in the experimental group were able to stay on for the full 120 seconds 
by the end of the study. For 15 rpm a slight incline was observed where both 
groups showed gradual improvement throughout the study. Animals in both 
groups were not able to stay on the rod as long at this speed, as it was the fastest 
and most difficult. For the second half of the study, it appears that the 
experimental animals were able to stay on the rod longer than the control group 
at 15 rpm. Similar results were observed from a study conducted by Shukitt-Hale 
et al. (2013), where aged rats given a blackberry diet showed an improvement in 
motor performance, particularly balance and co-ordination for the accelerating 
rotarod, wire suspension and the small plank walk.  
Novel object recognition for both the 1-hour and 24-hour trials had a DI above 
zero indicating that the animals in both groups were able to form a memory of 
the familiar object. The experimental group spent more time exploring the novel 
object suggesting that they may have better short-term memory compared to the 
control for the 1-hour trials. The DI for the 24-hour trials was substantially lower 
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than the 1-hour trials, which is expected as difficulty increases with time. A trend 
was observed for the 24-hour trials where the control group actually spent more 
time exploring the novel object compared to the experimental group. This 
fluctuation was likely influenced by the fact that two experimenters were 
involved with NOR testing during the 1-hour trials, making testing more efficient 
and coherent, whereas only one experimenter was present for the 24-hour trials 
resulting in the NOR testing taking twice as long. Shukitt-Hale et al., (2013), saw 
similar cognitive results to our 1-hour trials, where animals fed a blackberry-
enriched diet had significantly better short-term memory performance compared 
to the control group via Morris water maze testing.  
There are limitations that are associated with the use of rodents including 
housing conditions, strain, gender, biological rhythms, and route of drug 
administration (Balk et al., 2006). This particular study had a small sample size 
with both males and females of varying ages, which resulted in limitations 
regarding splitting up the animals into either the control or experimental group. 
The differences among the 18 C57BL/6 mice was due to the fact that those 
animals were the only wild-type mice we had in our colony at the time. It was 
decided that animals were to be split into the two groups based on their sex and 
their age, factors we thought would allow for the most accurate balance among 
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the two groups. However, even after dividing the animals evenly into the groups, 
the experimental group was slightly lighter overall than the control group (see 
Figure 3.27). This could have potentially skewed rotarod results as the lighter 
group may have been able to stay on the rod longer (Kovacs & Pearce, 2013). 
However, two-way ANOVA post hoc Bonferroni test was conducted and there 
were no significant differences between the performance of males vs females in 
the rotarod or significant differences between the ages (<3mo, 6mo-≦3mo, 
≧6mo). Female animals and younger animals are lighter (Kovacs & Pearce, 
2013), but they did not significantly perform better than the males or older mice 
on the rotarod. Therefore, this slight difference in the weights between the 
experimental groups may not have influenced the data, as weight did not affect 
the rotarod results. These insignificant results also show that the grouping based 
on age and sex, even though it was not exactly equal, did not significantly 
influence results. The groups were well balanced with each other, even though 
they differed.  
The duration of the study could have been longer as well. Initially we wanted 
to do a full 8-week study but do to time constraints it was cut down to 5 weeks. It 
would be interesting to see the results for the rotarod and NOR testing had the 
study gone on longer, and if some of the baseline trends we began to see would 
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become more apparent. It would be beneficial to repeat this study using animals 
of the same sex, age, and relative weight to maintain consistency. As well as 
repeat the study with aging animals, or animal’s models where pathological 
markers associated with AD or PD are present. A major goal of the pilot study 
was to verify palatability and weight gain so that we can take the next step and 
test in animal models of NDD. This way we could look at the levels of insoluble 
protein aggregates, such as alpha-synuclein and amyloid-beta, and determine if 
the addition of our blueberry extract to the diet is able to eliminate their presence 
and aggregation. This was seen in a study where transgenic AD mice were fed 
pomegranate juice, which is very high in polyphenols, or sugar water from 6-12.5 
months of age (Hartman et al., 2006). Mice given the pomegranate juice had 
significantly reduced amyloid-beta accumulation in the hippocampus compared 
to the mice given the sugar water.  
Determining the improvement of the symptoms associated with NDD such as 
memory loss with AD, and akinesia with PD, in NDD animal models would be 
beneficial as well. Casadesus et al. (2004) looked at the effect of a short-term 
blueberry diet administered to aging rats, where they saw an overall 
improvement of hippocampal plasticity and cognitive behaviors. Enhanced 
learning and memory, associated with age-related neurodegeneration was 
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improved by increasing the levels of insulin-like growth factor (IGF-1) and IGF-1 

















Chapter 5: Conclusions 
In conclusion, through biochemical analysis, this study has shown that low-
bush wild blueberry fruits and leaves have very high levels of phenolic 
compounds and high antioxidant activity. It was determined that the leaves had 
significantly higher antioxidant activity and total phenolic and flavonoid content 
compared to the fruits. The total anthocyanin content was significantly higher in 
the fruits. The total tannin content had mixed results, where one half of the 
samples had significantly higher levels in the fruits, and the other had 
significantly higher levels in the leaves. There was a significant difference 
between the phenolic levels in the fruits and leaves collected within and among 
the different locations. In the future, it may be beneficial to identify the genotypes 
of blueberry plants in particular areas that exhibit very high antioxidant 
scavenging abilities and breed them (Connor et al., 2002) in order to improve the 
efficacy of blueberry samples. 
Through in vitro experiments with mixed cultures, containing many different 
types of neurons and glia, as well as with pure rat neurons and microglia 
(ScienCell), a trend was observed where we saw an increase in the number of 
viable cells when blueberry extract was added to cells treated with 100 μM 
glutamate, 100 ng/ml alpha-synuclein, or 7.5 μM amyloid-beta, bringing them to 
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numbers close to the number of cells observed in the control wells. Even though 
these results are promising, replications of similar studies are needed in order to 
confirm these conclusions. There are several proposed mechanisms of action 
associated with the addition of phenolic compounds found in blueberries to help 
treat NDD and prevent neurodegeneration in the CNS. The diverse phenolic 
compounds present in this blueberry species may have additional mechanisms of 
action that could account for the potential neuroprotective role they exhibit. 
NDDs, such as PD and AD are having a major impact on the health of our aging 
population. Further enhancement and development of potential drugs and 
therapies to help treat these diseases will depend on further understanding of 
their underlying pathology. Through better understanding, we will be able to 
implement treatment in the early stages of these diseases by identifying potential 
biomarkers and high-risk individuals (Balk et al., 2006). The identification of 
potential biomarkers is extremely important, as cellular dysfunction occurs long 
before a lot of the symptoms associated with these diseases (Dauer & 
Przedborski, 2003). Early treatment could prevent significant damage and 
improve quality of life for those living with a NDD.  
Even though the addition and consumption of wild Newfoundland 
blueberries in this study has been shown to be beneficial and neuroprotective, it 
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is important not to overgeneralize or misinterpret data. For example, in vitro and 
in vivo rodent models are beneficial for investigating the mechanisms of action 
associated with the neuroprotective role of polyphenols, however they differ 
greatly with respect to clinical trials. In vitro and in vivo experiments can be 
strictly controlled (Balk et al., 2006), however there are many factors contributing 
to the bioavailability of the active metabolites in the human body (see section 
1.5).  There have been very few clinical studies looking at the effects of a 
blueberry enriched diet and most are highly debatable due to low sample sizes 
and inconsistencies during the study. A preliminary study conducted by 
Krikorian et al. (2010) looked at the effects of wild blueberry juice consumption in 
aging adults experiencing early memory changes over the course of 12 weeks. 
The results showed that the group that received the wild blueberry juice 
performed better with paired associate learning and list recall compared to the 
placebo group. A recent clinical study looked at the cognitive effects of the 
addition of 24g/day of blueberries to the diet of adults aged 60-75 (Miller et al., 
2018). The study was a double-blind placebo-controlled trial, and the results 
showed that the group given the fresh blueberries daily had significantly fewer 
repetition errors in the California Verbal Learning test compared to the control 
group. Better knowledge of the bioavailability of the phenolic metabolites found 
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in blueberries is essential if their effects are to be fully understood so further 
comprehensive clinical trials can be conducted (Manach et al., 2004). Further 
studies will need to be conducted in order to determine toxicity levels and proper 
‘dosing’ for an individual to experience a beneficial effect. This dose will not only 
depend on the amount required to elicit some form of neuroprotection, but how 
this dose can be properly and effectively introduced into an individual’s lifestyle.  
This study provides an essential step for determining the nature, distribution, 
mechanisms, and neuroprotective role of polyphenols in our diet by investigating 
the relation between the intake of these substances and the risk of NDD 
development and prevention. A blueberry enriched diet consisting of fresh fruits 
and leaves, or a nutraceutical product such as tea, powder, or juice, may slow the 
progression of NDD such as AD and PD. To summarize, blueberry fruits and 
leaves have the potential to influence future treatment or prevention of NDD, 
and may have many mechanisms of action associated with slowing the pathology 
of these diseases.  
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